Skip to content
National Cancer Institute (NIH), USA
2018
- Development of a novel platform for the identification of synthetic lethal genes in a Kras and Keap1-mutant mouse model of lung adenocarcinoma
- Understanding G alpha q/11 localization and trafficking in uveal melanoma
2017
- (PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma
- (PQ1) Cellular senescence as an initiating event in malignant transformation
- (PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
- (PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development
- (PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
- (PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
- (PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
- (PQ7) A multi-fluorescent intravital microscopy approach to study osteosarcoma
- (PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
- (PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
- (PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
- (PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment
- 2017 Cholangiocarcinoma Foundation Annual Conference
- 2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
- 4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy
- 5th International RASopathies Symposium
- A clones genomic stability as biomarker of its DNA-damage resilience
- A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma
- A highly specific NIRF/PET probe for the detection of cancer and metastases
- A Mobile-Support Program to Facilitate Nutritional Caregiving in Head and Neck Cancer
- A network-based approach for personalized treatment of Multiple Myeloma
- A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy
- A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
- A Novel Agent for Ovarian Cancer
- A novel approach for the selective inhibition of HIF-2a in kidney cancer
- A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
- A Novel Mouse Model for Uterine Leiomyoma
- A novel point of care test for oral and oropharyngeal cancer risk
- A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment
- A novel VLP vaccine to prevent EBV infection and EBV – associated malignancies
- A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
- A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS
- A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
- A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles
- A role for notch in self renewal in embryonal rhabdomyosarcoma
- A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
- A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
- A Unique Class of Reductively Activated Oncology Drugs
- ABT-199 based therapies to treat neuroblastoma
- AML-MutationCounter, a tool to detect residual and recurrent leukemia
- An 18F PET/NIRF Smart Probe for Identifying, Grading, and Visualizing Astrocytic Gliomas
- An Automated, Optical Imaging Platform for Early Detection of Oral Neoplasia
- An Imaging Technology for Intra-Operative Surgical margin assessment in oral and Head and Neck Cancers (OSCC)
- An in vivo model for CCNE1 amplified tumorigenesis
- Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia
- Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
- Anticancer peptide therapeutics
- Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
- Antivascular ultrasound therapy of primary liver neoplasia
- Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
- Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
- Area B: Precise DCE-MRI Assessment of Brain Tumors
- Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology
- Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma
- At the nexus of redox and signaling pathways: regulation of NAD+ kinase
- Augmented Neurosurgical Navigation Software Using Resting State MRI
- Automation of MicroC3 as a CDx for myeloma therapies
- BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
- Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells
- Biologic for the Treatment of High Risk B Cell Acute Lymphoblastic Leukemia
- Blood biopsy test for pan-cancer mutations with error-checking probes
- Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology
- Brain Tumor Epidemiology in the Era of Precision Medicine
- Breaking the paradigm: RhoA as a tumor suppressor in cancer
- Breakthrough sub-cellular 3D chemical composition research platform for live cells, based on the new invention of nanoscale – confocal photothermal IR micro-spectroscopy (n-CPIR)
- Building protected data sharing networks to advance cancer risk assessment and treatment
- Cadherin Regulation of Glioma Invasion: A Biophysical Perspective
- Cancer Cell Mechanical Profiling Analysis
- Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma
- Candidate Gene Resequencing of Germline Multiple Myeloma
- Canine Immuno Neurotherapeutics
- CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
- CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells
- Cell Cycle Blockade and Therapeutic Sensitization
- Cell survival by anastasis, a novel therapeutic target in cancer
- Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
- CEST MRI assessment of tumor vascular permeability using non-labeled dextrans
- Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
- CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM
- Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
- Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation
- Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies
- Chemoprevention of lung cancer with mitochondria-targeted honokiol
- Chemotherapy-induced MDSCs and antitumor immunity
- Clinical Development of JS-K for the Treatment of Cancer
- Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
- Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors
- CMV Infection and NK-Cell Therapy for Multiple Myeloma
- Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy
- Cohesin Mutations in Acute Myelogenous Leukemia
- Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
- Commercializing Praedicare Dx TM platform for guiding cancer treatments
- Common genetically altered pathways as targets for therapy in pancreatic cancer
- Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
- COMPREHENSIVE INFORMATIC ANALYSES OF AML GENOMES AND EPIGENOMES
- Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
- CONTRAST-ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCC
- Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma
- Coordinating center for the NCI small cell lung cancer research consortium
- Copy Number Alterations in Low Mutation Cancer
- Core Laboratory for Advanced PET and MRI image analysis
- Creation of in vivo active chemical probes for CAMKK2 to treat cancer
- Deciphering How Esco2 Loss Acts as a Penetrance Modifier
- Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery
- Defining a mechanism of LRP1B tumor suppression in glioblastoma
- Defining and targeting mechanisms of pancreas cancer pathogenesis
- Defining diverse roles of p53 in pancreatic cancer
- Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
- Defining Novel Genetic Dependencies in Spliceosome Mutant Leukemia
- Defining the barriers to immune surveillance in solid tumors
- Defining the Cellular Oncogenome of Kaposi Sarcoma
- Defining the non-myogenic origins of pediatric rhabdomyosarcoma
- DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA
- Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
- Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
- Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
- Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance
- Determining the role of DNMT-interacting RNAs in myeloid disorders
- Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer
- Developing differentiation therapy for the treatment of patients with acute myeloid leukemia
- Developing Therapeutic Strategies for Histone H3.3 Mutant Tumors via Rational Targeting of Specific DNA Repair Pathways
- Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
- Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
- Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer
- Development of a molecular diagnostic and prognostic signature for meningioma
- Development of a novel Virus-Like Particle vaccine-based cancer immunotherapy targeting PD-L1.
- Development of a protein drug for pancreatic cancer treatment
- Development of Cell-based Functional Tests for Rare Germline ATM Gene Variants in Hereditary Ovarian Cancer Families
- Development of Mantle Cell Lymphoma Proliferation Signature Assay
- Development of microfluidic blood-brain tumor barrier model to screen chemotherapeutic strategies for breast cancer brain metastases
- Development of mosaic mouse models of HCC for genetic interspecies inference
- Development of novel gallium-68 bisphosphonate for imaging bone metastases in prostate cancer
- Development of Novel Targeted Chemotherapeutics for the Treatment ofMalignant Pleural Mesothelioma
- Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
- Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
- Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
- Development of selective Pin1 inhibitors to target a common oncogenic mechanism
- Development of SHP2 inhibitors for targeted anti-cancer therapy
- Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
- Development, Characterization & Commercialization of a Viably Frozen, Patient-Inclusive Hepatocellular Carcinoma Tumor Bank
- Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
- Digital PCR quantification of BCR-ABL for CML diagnosis and monitoring in a LMICs setting
- Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
- Discovery of New Differentiation Agents for Neuroblastoma Therapy
- Discovery of Novel Therapeutics for Glioblastoma
- Discovery of Synthetic Lethal Targets for Recurrent Epigenetic Mutations in Acute Myeloid Leukemia
- Disrupting the immune and drug-privileged microenvironment in pancreas cancer
- Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
- Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
- Dissecting the role of the immune system in the radiation response of Kras-mutant tumors
- DNA adductomics of the urinary system
- Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma
- Early assessment of radiation response in brain tumors using quantitative temporal diffusion spectroscopy
- Early Detection of Ovarian Cancer Using Uterine Lavage and Duplex Sequencing
- Early prediction of colorectal liver metastases treatment response with ultrasound microvessel imaging
- Effects of Common Polymorphisms in Immune Sensors in Tumor Immunosurveillance
- Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas
- Elucidating the role of cell-specific Wnts in hepatocellular carcinoma
- Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer Model
- Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL)
- Elucidation of Human Natural Killer Cell Development
- Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
- Engineered precancerous cells and tissues for discovery of lung cancer drivers
- Engineering chimeric antigen receptors with VLR-mediated cancer recognition in CD5 edited gamma delta T cells
- Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Effect
- Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
- Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
- Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
- Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
- Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches
- Enhancing viral oncolysis with vasculostatin gene delivery
- Epigenetic and microenvironmental regulation of dormant disseminated cancer
- Epigenetic Mechanisms Driving Synovial Sarcomagenesis
- Epigenetic Regulation in High-Risk Leukemia
- Epigenetic regulation of cellular plasticity and cancer cell fate
- Epigenetic Regulation of Lipid Metabolism in Glioma Stem Cells
- Epigenetic regulation of metabolic rerpogramming in pancreatic cancer
- Epigenetic therapy for pancreatic cancer
- Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities
- Establishing the validity of brain tumor perfusion imaging
- Estimating and communicating spatial certainty when childhood cancers co-cluster
- Evaluation of metastatic brain tumor heterogeneity and physiological response to immunotherapy using advanced MRI
- Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
- Examination of ceramide signaling in the crosstalk between pancreatic cancer cells and the tumor microenvironment
- Examining the Heterogeneity of Fibroblasts in the Pancreatic Microenvironment
- Exosomes in tumor cell-mesenchymal stromal cell interaction
- Experimental Therapeutics by targeting Spleen Tyrosine Kinase
- Exploiting Mutant IDH1/2-induced Homologous Recombination Defects in Cancer
- Exploiting vulnerabilities in GIST using novel combination therapies
- Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
- Exploration of ZHX2 as a novel substrate of pVHL and an oncogenic driver of renal cancer
- Exploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortium
- Exploring the regulation and function of gap junction-mediated signaling in glioblastoma multiforme
- Exploring the therapeutic potential and pathogenic contribution of MTAP deletion in Glioblastoma
- Extracellular Vesicles in Small Cell Lung Cancer Early Detection
- Facile screening for esophageal cancer in LMICs
- FANCM in repair of stalled replication forks
- Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
- Feasibility of predicting AML response to induction chemotherapy
- FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics
- Field-deployable platform for prognostic hepatic cancer screening in low-resource settings
- First in human study with 18F-avb6-targeting peptide
- First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
- FOLFOX-induced kinome reprogramming in pancreatic cancer tumor xenografts
- Functional dissection of oncogenic enhancers
- Functional Effects of Ovarian Cancer Risk Variants
- Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
- Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
- Functions of human RAD51 and its paralogs during DNA interstrand crosslink repair
- GABPB1L-mediated activation of the mutant TERT promoter as a therapeutic target in glioblastoma
- Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
- Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
- Glycine metabolism in cancer
- Grail-targeting breaks the immune tolerance to melanoma
- GRIM19 for head and neck cancer therapy
- Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
- Hepatobiliary Cancers: Pathobiology and Translational Advances
- High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment
- Identification of Essential Areas of the Brain in Pre-Operative Brain Tumor Patients Using BOLD fMRI and Independent Physiological Parameters
- Identification of microRNA variants associated with acute lymphoblastic leukemia
- Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
- Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer
- Identifying novel effectors of oncogenic Kras in pancreatic cells via proximity labelling
- Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
- Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma
- Image-guided, sonoporation-enhanced immunotherapy for pancreatic cancer treatment
- imaging Radiation-Associated Dysphagia (iRAD)
- Immune epigenetic biomarkers of survival in glioma epidemiology
- Immune Impact on Cancer Chemoresistance
- Immuno and Epigenetics of Hematopoietic Cell Transplantation
- Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma
- Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody
- Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
- Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts
- Implications of Metabolic Regulation of BCL-2 Dependence for Myeloma Therapy
- Improving Adverse Event Reporting on Cooperative Oncology Group Trials
- Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles
- Improving the disposition of antileukemic asparaginase after drug-induced immunotoxicity
- Improving the radiation therapeutic ratio by inhibiting proinflammatory cytokines
- In vivo anti-PD1 gene therapy
- In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies
- Inducible systems for studying liver tumor mainenance in vivo
- INHANCE Consortium
- Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy
- Instructive role of MLL fusion proteins in lineage determination and leukemogenesis
- Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer
- Integrative Analyses to Identify Pancreatic Cancer Susceptibility Genes
- Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer
- Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma
- Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma
- Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
- Interstitial Intensity Modulated Photodynamic Therapy (i-IMPDT)
- INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
- Investigating 53BP1 dephosphorylation as a critical determinant of PARP
- Investigating Brutons Tyrosine Kinase Dependency in Primary Central Nervous System Lymphoma
- Investigating cellular heterogeneity in lung cancer
- Investigating developmental Hox programs as determinants of sarcomagenesis
- Investigating roles for transcriptional co-activators Eya2 and Eya3 in normal development and rhabdomyosarcoma
- Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence
- Investigating the Mechanisms of Resistance to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
- Investigating the role of miR-155 and the interferon response in FLT3-ITD+ AML
- Investigating the Role of Transcription on DNA Damage at Early Replicating Fragile Sites
- Investigation of antibody-drug conjugates of a novel target
- Ionizing radiation induced hematological malignancies
- IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
- Isolation, characterization and translational development of glioma stem cells
- Isozyme-selective ALDH Inhibitors for Sensitizing Ovarian Cancer Stem-like Cells to Chemotherapy
- KLF6: A driving factor of lung adenocarcinoma
- K-Ras sumoylation in cell proliferation and transformation
- Label free microfluidic isolation, characterization and ex vivo expansion of CTCs
- Large aperture and wideband modular ultrasound arrays for the diagnosis of liver cancer
- Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing
- LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
- Leukemia stem cell polarity and differentiation therapy
- Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
- Macrophage-based ovarian cancer immunotherapy
- Manipulation of three-dimensional chromatin structure to regulate oncogenes in breast and ovarian cancer.
- Master Regulatory MicroRNAs in Glioblastoma
- Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
- Mechanism of IL-10 protective effect in development of childhood B cell acute lymphoblastic leukemia
- Mechanism-based approach to combine histone deacetylase inhibitors with PARP inhibitors for therapy in AML
- Mechanism-based drug repurposing and novel treatments for glioblastoma
- Mechanisms mediating resistance to ibrutinib in Non-Hodgkins lymphoma
- Mechanisms of Formation and Progression of Preleukemic Stem Cells
- Mechanisms of KLF4 suppression in pediatric leukemia
- Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries
- Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Lung Adenocarcinoma
- Mechanistic Dissection of an Arginine Methyltransferase Dependency in Cancer
- Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma
- Metabolic basis of B cell lineage leukemia relapse
- Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
- Metabolic rewiring regulates cancer growth and tumor-associated immune responses
- Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
- Metformin Supplementation for Ovarian Cancer Prevention: A Prospective Preclinical Study
- Mitochondrial Dynamics in Brain TumorInitiating Cells
- Mobile app for positive psychology intervention to enhance smoking cessation outcomes
- Modeling Mdm2- and 12q amplicon-driven sarcoma
- Modulation of Immune Checkpoints by Self-Deliverable RNAi for Adoptive Cell Transfer
- Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis
- Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
- Molecular diagnostic and prognostic signatures for PTCL
- Molecular Imaging and Theranostics of Cancer
- Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma
- Molecular Mechanism and Therapy for Ocular Melanoma
- Molecular Mechanisms in Gastrointestinal Stromal Tumor
- Molecular mechanisms of Nutrient sensing in cancer
- Molecular Mechanisms Underlying Environmental Effects that Influence Penetrance in Lynch Syndrome-Associated Endometrial Cancer
- Molecular pathways and targeted therapies in human leukemia
- Molecular regulation and therapeutic targeting of the TSC signaling network
- Molecularly-Targeted Ultrasound in Ovarian Cancer
- Mouse models to discover new drivers of medulloblastoma
- MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
- MUC16 in Pancreatic Cancer Progression and Metastasis
- Multi-Modal Imaging of Psychostimulant Effects on Executive Function Post-RRSO
- Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
- Multispecies Comparison of the Impact of Obesity on GVHD/GVT
- MUTANT AND WILD TYPE WT1 IN AML
- MYB family alterations in pediatric gliomas
- MyD88-dependent mechanisms of Helicobacter pylori-induced gastric cancer progression
- Nanovaccine platforms to combat pancreatic cancer
- New DNA repair alterations in hereditary cancer development
- New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss
- NFAT activation in kGPCR tumorigenesis
- Nicotinamide N-Methyltransferase (NNMT) as a master regulator of cancer stroma
- Non-canonical WNT signaling in the invasion and metastasis of uveal melanoma
- Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
- Noninvasive prediction of tumor response to gemcitabine using MRI
- Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
- Notch signaling in liposarcoma
- Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
- Novel DNA Repair Inhibitors for Cancer Therapy
- Novel Glyco-tests to Predict Chemoresistance
- Novel Inhibitors of PSMB7 and PSMB10 for the Treatment of Multiple Myeloma
- Novel mechanisms and therapeutic strategies of refractory leukemia
- Novel model to study PDAC using normal human pancreatic tissue
- Novel monobody therapy for pancreatic cancer
- Novel Nanodrug Delivery System to Optimize Dose of Oncology Drugs
- Novel Nano-Plasmonic Technology for Quantitative Analysis of Cancer Exosomes
- Novel Relationships between BER Glycosylases and Mutagenic DNA Adducts
- Novel targeted therapeutic for advanced metastatic disease
- Novel targeted therapies for isocitrate dehydrogenase mutantcholangiocarcinoma
- Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
- Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma
- Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
- Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors
- Omics Approach to Interrogating Mechanism of ETV5 in Glioma
- Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
- Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
- Oncogenic programs driven by notch signaling in B-cell lymphoma
- Optical and electromagnetic tracking guidance for hepatic interventions
- Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents
- Optical imaging of pancreas cancer organoids for drug development and personalized treatment
- Optimizing Delivery of Oncolytic Measles Virus Strains with Cell Carriers
- Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
- Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
- Optimizing the Treatment of Pancreatic Adenocarcinoma
- Oral formulation for novel inhibitor of Ras driven cancers
- Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery
- Osteopontin-targeted therapy for primary CNS lymphoma
- Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia
- Pancreatic Cancer Detection Consortium
- Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
- Pathophysiological role and therapeutic potential of microRNA-29 in pancreatic cancer autophagy
- Patient-centered leukemia diagnostic and monitoring using the HemoLink-MD
- Patient-derived glioblastoma in vitro and in vivo studies of tryptophan metabolism via the kynurenine pathway
- Patient-Matched Stem Cells of the Barretts-Dysplasia-Adenocarcinoma Sequence
- PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL
- PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
- PDGFR beta signaling in the tumor microenvironment of metastatic breast cancer
- PDL1 expression on B cells: a potential marker of pre-tumor cells in AIDS-NHL
- Peptide-based targeted molecular imaging for early detection in pancreatic cancer
- Personalized cancer models to discover and develop new therapeutic targets.
- pH Transistor Nanoprobes for Detection of Occult Nodal Metastases
- Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma
- Phenotype Transitions in Small Cell Lung Cancer
- Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma
- Potential Role of the Novel Angiopoietin-like Protein RIFL/Angptl8 in Hepatocellular Carcinoma
- PQ6: Role of Cellular Senescence in Late Effects of Childhood Cancer Therapy
- Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers
- Preclinical development of a DLL3-targeted theranostic for small cell lung cancer
- Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials
- Probing the role of a highly expressed lncRNA in hepatocellular carcinoma
- Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
- Prodrug treatment for CML
- Programa de ARBOLES Familiares: Assessing Risk of Breast Cancer through Outreach to Latinas with Education and Support
- Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
- Proteasomal regulation of BMI-1 and impact on tumor initiating cells in glioblastoma
- Protein and proteolytic activity biomarkers of early stage pancreatic cancer
- Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
- Proteogenomic Translational Research Center for Clinical Proteomic
- Proteomics of Metastatic and Non-Metastatic Uveal Melanoma
- Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
- Quantitative imaging tools to derive DW-MRI oncological biomarkers
- Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response
- Quantitative Staging and Therapeutic Response in IDH-1 Mutated Glioblastomas
- QuBBD: Precision E –Radiomics for Dynamic Big Head & Neck Cancer Data
- Raising the Therapeutic Index of Photodynamic Therapy with Targeted Nanosyringes
- Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
- Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip
- Rational Translation of EZH2 Targeted Therapy in Germinal Center B-cell Lymphoma
- Reconstituting human pancreatic cancer development for translational research
- Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
- Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
- Regulation of Pancreatic Oncogenesis by the Gut Microbiome
- Regulation of TAL1/SCL in T-Cell Leukemia
- Regulation of tumor growth and metabolism by hyperinsulinemia
- Regulatory role of long noncoding RNAs in normal and cancer cells
- Reprogramming PDAC tumor microenvironment to improve immunotherapy
- Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
- Resistance To Targeted Immunotherapies:CART19 as a Paradigm
- Resolving the obesity paradox in kidney cancer
- Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
- Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
- RNF128 Regulation of TP53 in Barretts Progression
- Robust Predictor of Breast Cancer Risk
- Role of autophagy in normal and transformed hematopoietic stem cells
- Role of CRABP-II in pancreatic cancer metastasis
- Role of ER stress-driven IRE1α-XBP1 Signaling in Lung Cancer Pathogenesis
- Role of hedgehog signaling in tumor-associated macrophage polarization
- Role of long non-coding RNAs in sarcoma pathogenesis
- Role of m6A mRNA methylation in Neuroblastoma
- Role of MAST1 kinase in cisplatin resistant cancers
- Role of microbiota in therapy to ovarian cancer
- Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma
- Role of MIF in myeloma bone homing and drug response
- Role of mismatch repair in regulating effects of PARP inhibition in Glioblastoma
- Role of p62/SQSTM1 in obesity-induced liver cancer
- Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia
- Role of PTEN and PI-3 kinase in medulloblastomagenesis
- Role of the hexosamine biosynthesis pathway in pancreatic cancer.
- Role of the Histone Methyltransferase MLL4 in Medulloblastoma
- Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents
- Self-expanding hydrogel for pelvic brachytherapy: a novel method for vaginal packing and customized radiation therapy
- Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response
- Sequence variation in mtDNA and extreme survival in glioblastoma
- Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment
- Serotonin drives cancer stem cell maintenance and glioblastoma progression
- Seventeenth Annual Meeting of the Rocky Mountain Virology Association
- Simultaneous Detection of Proteins and Whole Transcriptomes in Single Cells
- Single-cell analysis of tumor-microenvironment interactions in follicular lymphoma
- Single-molecule mechanical detection of protein and microRNA cancer biomarkers
- Sirolimus Delivery from Esophageal Stents to Prevent Scarring after Mucosectomy
- Small-molecule MDM2 degraders
- SMART-ACT: Spatial Methodologic Approaches for Risk Assessment and Therapeutic Adaptation in Cancer Treatment
- Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer
- Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients
- Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma
- SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
- STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
- State of the Science: Healthy Weight Maintenance During Pediatric, Adolescent, and Young Adult Cancer Treatment
- Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation
- Statistical Methods for Characterizing Tumor Heterogeneity at the Single Cell Level
- Steady states and cellular transitions associated with carcinogenesis and tumor progression
- Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
- Stroma targeted theranostic nanoparticles for pancreatic cancer
- Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases
- SWI/SNF complex in mouse HCC development
- Syndecan-1 (CD138) and its synstatins: targeting invasion, survival and angiogenesis in myeloma
- Synergistic role of signaling and epigenetics in leukemic transformation
- Synthetic and Mechanistic Studies of Myrocin Antitumor Agents
- Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
- Systemic RNA interference to reactivate p53 tumor suppression
- T antigens inhibit Notch to promote Merkel cell carcinoma in skin stem cells
- Targeted activation of autoimmune checkpoints in B cell malignancies
- Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again
- Targeted therapeutics for ovarian cancer and its microenvironment – treatment and theoretical modeling
- Targeted Therapies for Richters Transformation
- Targeting CDK4/6 for pancreatic cancer treatment
- Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
- Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma
- Targeting Cyclin E in Ovarian Cancer with Histone Deacetylase Inhibitors
- Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
- Targeting DEPTOR in multiple myeloma
- Targeting DNA Base Excision Repair in Acute Myeloid Leukemias
- Targeting Human Cancers with Hemizygous Deletion of TP53
- Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy
- Targeting hyaluronan synthesis and signaling with BET inhibitors in pancreatic cancer
- Targeting inflammation and immune response in HNSCC therapy
- Targeting Kidney Cancer-associated CD105 expression with a novel Listeria-based Vaccine Approach
- Targeting Kinesin Family Member 15 for the Treatment of Cancer
- Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
- Targeting macrophages to sensitize myeloma to immune checkpoint blockade
- Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma
- Targeting metabolic vulnerabilities in glioblastoma
- Targeting microRNAs to eradicate leukemia stem cells
- Targeting novel DAMP mediated signaling pathways to mitigate GVHD
- Targeting TET1 signaling to treat acute myeloid leukemia
- Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
- Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia
- Targeting the p62 signalosome in leukemia.
- Targeting the TGIF/Twist1 network in osteosarcoma
- Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
- Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
- Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
- Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer
- The cohesin complex as a tumor suppressor in myeloid leukemia
- The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
- The Effect Of Cohesin Mutations In Hematologic Malignancies
- The epigenetic mechanisms of high-grade pediatric glioblastoma
- The Impact of Maternal Obesity on the Reprogramming of the Metastatic Microenvironment
- The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships across Time and around Periods of Distress
- The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
- The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
- The mRNA methylation program in leukemia
- The Novel Role of REST in the Development of Pancreatic Ductal Adenocarcinoma
- The Pancreatic Cancer Microenvironment
- The role and mechanism of FTO in leukemogenesis and drug response
- The role of AID/APOBEC3 proteins in genome instability in multiple myeloma
- The Role of CD147 in Glioblastoma Invasiveness
- The Role of DLST in Leukemogenesis
- The role of DNMT3A in gene regulation and stem cell expansion
- The role of histone demethylases in acute myeloid leukemia cell persistence
- The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival
- The Role of ITIH5 in Suppressing Pancreatic Cancer Metastasis
- The role of JMJD6 in MYC-mediated neuroblastoma
- The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.
- The role of p120ctn in PDAC epithelial-to-mesenchymal transition and metastasis
- The role of PLAG1 in Wilms tumor formation
- The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer
- The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis
- The Role of Suv420h1 Histone Methyltransferase in MYC-Driven Tumorigenesis
- The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer Biology
- The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
- The role of X chromosome inactivation in ovarian cancer
- The SMYD3-ERK5 signaling module in pancreatic cancer
- The Unfolded Protein Response in Glioblastoma
- Therapeutic disruption of Connexin43-mediated microtubule regulation to target glioblastoma cancer stem cells
- Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery
- Therapeutically Exploiting a Newly Isolated Neural-Like Stem Cell Against GSB
- Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
- Tools to Measure Non-Receptor Tyrosine Kinase Activities for Drug Discovery and Biomarker Analysis
- Transcriptional Regulation of Lung Cancer Identity
- Translating genomic discoveries to improved outcomes for high risk acute leukemia
- TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
- Trans‐nasal delivery of chemotherapy to glioblastoma using magnetic nanoparticles and magnetic focusing
- Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers
- Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma
- Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer
- U2C Kids First Admin Supplement – cloud-based data storage and compute
- Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
- Ultrasensitive Quantitation of Circulating Tumor DNA
- Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease Using Skin Elasticity as a Biomarker
- Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
- Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome
- Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma
- Understanding metabolic pathways that support redox homeostasis in cancer
- Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors
- Understanding succinate-induced global transcriptional and epigenetic reprogramming and identifying unique vulnerabilities intrinsic to SDH-deficient cells
- Understanding the consequences of oncogenic mutations on FGFR signaling
- Use of chromatin accessibility maps to discover novel regulatory circuits in aggressive B cell lymphomas
- Using microfluidic single cell culture to characterize cancer cell asymmetric division
- Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
- Vitamin D and Follicular Lymphoma
- White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy
- Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
- Wnt/?-catenin Signaling in Pancreatic Oncogenesis
2016
- (10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
- (9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
- (PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors
- (PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
- (PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
- (PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
- (PQ1) Progression of the airway field of injury to Kras mutant lung cancer
- (PQ11) Reversing exosome-mediated immune suppression – a novel strategy for cancer therapy
- (PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
- (PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
- (PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
- (PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach
- (PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
- (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
- (PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
- (PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
- 124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
- 15-PGDH in Cholangiocarcinogenesis
- 2016 AUA Urologic Oncology Research Symposium: Forging New Paths in Research to Advance Urologic Oncology”
- 2016 Lysosome and Endocytosis Gordon Research Conference & Gordon Research Seminar
- 2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization
- A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
- A Clinical Validation Center for Early Detection of Pancreatic Cancer
- A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy
- A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
- A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines
- A network platform to connect drug response and prognosis phenotypes for cancers
- A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia
- A novel oncogenic driver in Ewing sarcoma
- A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
- A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC)
- A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
- A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
- A rapid spontaneous murine model of CN-AML
- Aberrant signaling in acute myeloid leukemia
- ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer
- Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
- Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
- Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes
- Allogeneic antibody therapy for malignant mesothelioma
- Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma
- Analysis of TET2 function in acute leukemia
- Anti-CD138-IFN fusion proteins for the immunotherapy of multiple myeloma
- Anti-CTGF Therapy for Squamous Cell Lung Cancer
- Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma
- Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)
- Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
- beta1 integrin/c-Met: a receptor complex driving invasive resistance to anti-angiogenic therapy in glioblastoma
- Biochemical and Functional Characterization of the Mutagenic Cytidine Deaminase APOBEC3B in the contextof Squamous Cell Lung Carcinoma
- Biologic and Preclinical Studies of Myeloid Malignancies
- Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia
- Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
- Blocking NK cell shedding of CD16a to increase cancer cell killing
- BM NICHE DISRUPTION AND IMMUNOTHERAPY IN HEMATOLOGICAL MALIGNANCIES
- Brain Tumor Epidemiology Consortium
- Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
- Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
- CAR-T cell control through orthogonal antibody-based switches
- Cbx-3/HP-1gamma deficiency confers anti-tumor immunity
- CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
- CDK9 and cyclin regulators in Medullary Thyroid Cancer
- Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severity
- Cellular Pathogenesis of Fibrolamellar Hepatocellular Carcinoma
- CELLULAR PATHWAYS AFFECTING ONCOLYTIC VIRUS-HOST INTERACTIONS IN CANCER
- Center for Modeling Tumor Cell Migration Mechanics
- Center for Multiple Myeloma Nanotherapy
- Center of Excellence for High Throughput Proteogenomic Characterization
- Characterization and targeting of leukemia stem cell metabolism
- Characterizing HBEGF in glioma formation and maintenance
- Characterizing Histone Deacetylases in Rhabdomyosarcoma
- Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women
- Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma
- Chemical biology of superstolides–a novel class of anticancer natural products
- Chemical genetic investigation of metastatic seeding in pancreatic ductal adenocarcinoma using novel multiplexed in vivo screening
- Chemotherapy resistance induced by SETD2 loss in leukemia
- Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies
- Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
- Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
- CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELLS DURING CHEMOTHERAPY AND TRANSPLANTATION
- Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia
- CMV infection and NK-cell therapy for multiple myeloma
- COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
- Communicate and LEarn About youR Variant of Uncertain Significance (CLEAR VUS)
- Comparative Effectiveness of Cancer Research: Use Data from Multiple Sources
- Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients
- Comprehensive genetic dissection of druggable KRAS targets
- Computational Analysis of Subclonal Evolution in Chronic Lymphocytic Leukemia
- Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
- Convection-enhanced Delivery of Radiosensitizer-Encapsulating Nanoparticles for the Treatment of Pediatric Brainstem Gliomas
- Coordinate Regulation of p53 and c-Myc in HTLV-1 and HPV-induced Carcinogenesis
- Core Essential Genes in Primary Effusion Lymphoma Cell Lines
- Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm
- Critical resources provided by UNMC RAP biorepository stimulate cancer research
- Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
- Cytokine induced RelB/p50 complexes drive mesenchymal glioma progression
- Cytokine-induced RelB phosphorylation in glioblastoma multiforme
- Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery
- Defective Myoblast Fusion Signaling in Rhabdomyosarcoma Pathogenesis
- Defining epigenetic vulnerabilities of subtype-specific lung cancers
- Defining Monoclonal Gammopathy of Unknown Significance in Automated Health Data
- DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
- Defining the formation and function of carcinoma-associated mesenchymal stem cells in the ovarian cancer microenvironment
- Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor Syndrome
- Delineating roles for a novel tri-protein complex (TRIM44) in the multiple myeloma stem cell niche
- Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers
- Designing durable apoptosis-targeting therapies for acute myeloid leukemia
- Determinants of acquired resistance in small cell lung cancer
- Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
- Determining the Role of BCOR Mutations in Myeloid Malignancies
- Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
- Determining the Role of Tumor-Associated Macrophages in oHSV Antitumor Efficacy in Ewing Sarcoma and Rhabdomyosarcoma
- Deubiquitinases in regulation of BRCA1 pathway
- Developing a translational pipeline for NF1-mutant malignancies
- Developing Therapy for the Treatment of Cholangiocarcinoma
- Development and testing of MRI-mediated radiofrequency ablation system and probes
- Development of 18F-based Pretargeted PET imaging strategies for the PET imaging of cancer
- Development of a mouse model of pediatric high-grade gliomas
- Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
- Development of Casein Kinase 1d and 1e Inhibitors for Treatment of Brain Cancer
- Development of cell-free DNA assays for HCC screening and liquid biopsy
- Development of DNA Polymerase θ Inhibitors for Precision Medicine in BRCA Deficient Cancers
- Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer
- Development of multifunctional biodegradable drug-loaded polymer stents for inoperable esophageal malignancies
- DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER
- Development of novel selective Rac inhibitors for refractory leukemias
- Development of novel therapies for megakaryocytic malignancies
- Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment
- Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
- Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia
- Development of Targeted Nanotechnology Platform for Pancreatic Cancer
- Development of Transporter Targeted Platinum Drugs for Glioblastoma
- Developmental studies to inform clinical stratification and targeting of SHH MB
- Digital Analysis of Plasma miRNA populations in Pancreatic Cancer
- Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma
- Discovery and Characterization of Mutations in Breast and Ovarian Cancers
- Discovery and Characterization of New Human Cancer Viruses
- Discovery of pathogenic germline variants in pediatric cancers using genomics.
- Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
- Dissecting gastric cancer clonality with genomic analyses and patient xenografts
- Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus
- Dissecting the molecular and functional role of Sox2 in synovial sarcoma
- Drosophila as a low complexity model for human neoplasms
- Early Detection of Hepatocellular Carcinoma
- Early detection of ovarian cancer by serum marker and targeted ultrasound imaging
- Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
- Early Stage Diagnosis of Kaposis Sarcoma in Limited Resource Settings using KS-Detect
- e-Assist: A Post-Visit Patient Portal Tool to Promote Colorectal Cancer Screening
- Ect2 Function in Lung Adenocarcinoma Initiation and Maintenance
- Elucidating and exploiting the mechanisms by which IL-6 and IL-8 facilitate osteosarcoma metastasis
- Elucidating KRAS-specific vulnerabilities in pancreatic cancer
- Elucidating the role of the Nrf2 anti-oxidant pathway in lung adenocarcinoma
- Enhancing anti-neoplastic activity of metformin in prostate cancer
- Enhancing at-Risk Latina Womens Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
- Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
- Enhancing immune therapy in pancreatic cancer by targeting IL-6
- Epidemiology and biology of lncRNAs in ovarian cancer
- Epigenetic activity of normal and cancer-associated mutant H1 linker histones
- Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia
- Epigenetic Mechanisms of Oncohistone Detoxification
- Epigenetic Modulation of Wnt/Beta-catenin Pathway and Tumorigenesis of Glioma Cells by KDM4C
- ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma
- ERASE – A new dual thermal ablation/SCN device system for treating pancreatic cancer
- ESTABLISHING A CONDITIONAL TELOMERASE KNOCK-IN ALLELE IN A HAPLOID CANCER CELL LINE TO IDENTIFY REGULATORS OF ALT THROUGH GENETIC FORWARD SCREENS
- Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML
- Evolutionary Heterogeneity of High Grade Glioma
- EWS/FLI Regulates Transcriptional Activation in Ewing Sarcoma via Length Dependent GGAA Microsatellites
- Examining the role of normal hematopoiesis in supporting incipient myelodysplasia
- Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer
- Exosomic microRNAs and drug resistance in AML tumor microenvironment
- Exploiting Altered Porphyrin Synthesis for Metabolic Imaging of Glioblastoma
- Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
- Exploring BCL-XL addiction in pancreatic ductal adenocarcinoma
- Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer
- Exploring oncogenic translation programs in cancer
- Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis
- Extracellular DNA in regulation of multiple myeloma
- Fate and efficacy of targeted therapies for metastatic tumors
- Fgl-2 targeted therapy for reversing multi-modality immune suppression
- First in-human PET imaging studies of NIS reporter [18F]BF4
- Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
- FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
- From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
- Functional Characterization of Glioma GWAS Variants
- Functional Dissection of the K27M Histone Mutation In Gliomagenesis
- Functional Interrogation of Kdm6a-Dependent Tumor Suppression during Pancreatic Cancer
- Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma
- Gastrointestinal Meeting on Intestinal Metaplasia in the Esophagus and Stomach
- Genetic Cytology for Ovarian and Endometrial Cancer Screening
- Genetic Epidemiology of non-Hodgkin Lymphoma
- Genome-edited uveal melanoma cell lines for investigating constitutively active GNAQ and GNA11
- Genomic approaches to guide molecular classification of glioma
- Genomic Heterogeneity and the Small Renal Mass
- Genomics and Mechanisms of Esophageal Carcinogenesis
- Glial tumor image-guided surgery and treatment
- Glioblastoma, Glioblastoma Stem Cells and Radiotherapy
- Gold Nanoparticle Treatment of Glioma
- Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort
- Harnessing Host Response to Prevent Myeloma
- Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
- Health Services Career Development: Improving Medical Decisions in Ovarian Cancer
- Hexokinase 2 in liver cancer
- High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
- High-Throughput Generation of Pancreatic Organoids with Controlled Stromal Milieus using Microraft-Based Cell Sorting
- Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer.
- Histone Modification and Transcription Elongation in Human Cancer
- HMGB1 as Link Between Hepatocellular Injury and HCC
- Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
- How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
- HSC-Independent Mechanisms Underlying JMML
- Humanized bone marrow-like model to study patient-derived myeloma xenografts
- Hypermutation and malignant progression in an expanded cohort of TMZ treated LGG patients from different molecular subgroups
- Identification of chemosensitizing agents that block DNA repair by the Fanconi Anemia/Bloom Dissolvasome complex
- Identification of Long Non-coding RNAs as Novel Biomarkers for Heterogeneous Glioblastomas
- Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
- Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis
- Identifying a nodal point for G alpha q signaling in eye disease
- Identifying epigenetic drivers and their targets in aggressive breast and ovarian cancers
- Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer
- Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer
- Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A
- IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
- Image-guided ultrasound therapy and drug delivery in pancreatic cancer
- Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
- Imaging Liver Cancer Proliferation
- Imaging of Hematologic and Oncologic Disorders
- Imaging Tumor Associated Macrophages in Bone Sarcomas
- Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
- Improving Sorafenib; a multi-targeted kinase inhibitor used for the treatment of hepatocellular carcinoma by mechanistically dissecting out its underlying targets and anti-targets
- In vivo imaging of Stem cell loaded oncolytic viruses for cancer therapy
- Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer
- Integrated Signaling in Pancreatic Cancer Progression
- Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
- Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies
- INTEGRATIVE IMAGING INFORMATICS FOR CANCER RESEARCH
- International Registry of Werner Syndrome
- Interpreting limits to nanoparticle delivery in high-stroma low-perfusion tumors
- Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging
- Intratumor heterogeneity and therapeutic resistance
- Intra-tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
- Investigating L-2-hydroxyglutarate in normal hematopoiesis and leukemogenesis
- Investigating the development and maintenance of tumor-associated tertiary lymphoid structures in an autochthonous mouse model of lung adenocarcinoma
- Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function
- Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells
- Investigating the Role of Chronic Inflammation in the Pathogenesis of Myeloid Malignancies
- Investigating the Role of Novel Drug Target TBK1 in Pancreatic Cancer Pathogenesis
- Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis
- Investigating the Role of the Mek5-Erk5 Kinase Module in Small Cell Lung Cancer
- Investigation and targeting of the transcriptional and epigenetic landscape of Small Cell Lung Cancer
- iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
- Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification
- JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer
- Kinase Dependent Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer
- Kinase Inhibition in Kidney Cancer
- Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
- Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions
- LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS
- Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
- Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis
- Loss of oncogene insulation drives IDH1 mutant glioma
- Mapping cancer micro-environments for acute leukemia
- Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
- Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors
- Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
- MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
- MDSC-tumor crosstalk in prostate cancer progression and castration resistance
- Mechanism behind CCL21/CCR7-mediated pancreatic cancer progression
- Mechanism of evasion by ovarian cancers from anti-VEGF therapy
- Mechanism of gp96/grp94 in regulating plasma cells and myeloma
- Mechanism of Ikaros Tumor Suppression in progenitor B cell leukemia
- Mechanism of Met-Induced Hepatocyte Survival
- Mechanism of the methyltransferase Prdm3 in MLL leukemogenesis
- Mechanisms governing metastatic dormancy and reactivation
- Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)
- Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
- Mechanisms of Escape from TGFβ Tumor Suppression in the Pancreas
- Mechanisms of Human Lymphoid Chromosomal Translocation
- Mechanisms of Pancreatic Carcinogenesis
- Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
- Mechanisms of radioresistance and strategies for radiosensitization in OCCC
- Mediator Kinases and AML Cell Proliferation
- Mengovirus Replicon for Enhanced Oncolytic Virotherapy
- Mentored Patient Oriented Research in Lymphoma
- Mentoring and Research in Cancer Stem Cells
- Metabolic basis of B cell lineage leukemia relapse
- Metabolic Imaging of Brain Tumor Response to Therapy
- Methyltransferase Contributions to Genomic Stability and Cancer
- Microfluidic assay to predict patient-specific multiple myeloma clinical response
- MicroRNA and Transcription Factor Co-regulation in Cancer
- MicroRNAs Modulate Therapy Resistance in Prostate Cancer
- Modeling pediatric glioma in human ES cells:mechanistic and therapeutic insights
- Modeling pediatric gliomas using a human pluripotent stem cell-based platform
- Modeling the impact of mutations in ubiquitin ligase genes on transcriptional programs in endometrial cancer
- Modifier of Cancer Sensitivity to Statins
- Modulating signaling pathways in endothelial cells to abate leukemic progression.
- Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
- Modulation of Host Cell Exosome Content and Function by EBV LMP1
- Molecular and cellular mechanisms of SCLC metastasis
- Molecular Basis of KSHV oncogenesis
- Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma
- Molecular Dissection of an Arntl2 induced pro-metastatic secretome
- MOLECULAR GUIDED SURGERY FOR IMPROVED RESECTION OF GLIOBLASTOMA MULTIFORME
- Molecular Interactions of APOBEC3 Enzymes with the Cancer Genome
- Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer
- Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
- Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma
- Monitoring tumor subclonal heterogeneity over time and space
- Monocyte promotion of therapy resistance by immune and non-immune mechanisms
- MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer
- Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
- Multifunctional, GBM-activatable nanocarriers for image-guided photochemotherapy
- Multiplexed exosome analyses with DNA barcoding
- Myc transcriptional regulation in T-ALL
- Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
- Nanoparticle Delivery System for Ewing Sarcoma Treatment
- Nanoparticle modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer
- Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors
- Nanotechnology enabled targeting of p53 deficiency in human cancer
- Near infrared intraoperative molecular imaging of lung adenocarcinoma
- Neurotensin in Fibrolamellar Liver Cancer
- New Frontiers in Pediatric Stem Cell Transplantation
- New HuR inhibitor against pancreatic cancer EMT and CSCs
- New Paradigms for Targeting Truncal Driver Mutations
- New Ways of Targeting K-Ras
- Notch signaling in small cell lung carcinoma
- Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
- Novel Bone-Targeting Combination Therapy for Osteosarcoma
- Novel functions of D-type and E-type cyclins in normal and in cancer cells
- Novel immunotherapy strategy for treatment of pancreatic cancer
- Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
- Novel Ras inhibitor prodrug for colorectal cancer
- Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
- Novel role of the polycomb repressive complex PRC2/EZH2 in glioblastoma
- Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
- Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis
- Novel Strategies for Precision T-cell Therapies
- Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies
- NSD1 Inactivation in Head and Neck Cancer
- Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
- Oncogenic programs driven by Notch signaling in B-cell lymphoma
- Opening of the Blood-Brain Barrier to Antitumor Agents
- Optimal DNA Brain-Penetrating Nanoparticle (DNA-BPN) Formulation for Glioblastoma (GBM) Treatment
- Optimization of a clinical stage nanoparticle drug delivery platform
- Optimizing Immunotherapy Strategies to Eliminate Recurrences after Cancer Surgery
- Optimizing Ultrasound Enhanced Delivery of Therapeutics
- Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
- Overcoming IMiD resistance in Myeloma
- Overcoming Primary Ibrutinib Resistance in Mantle Cell Lymphoma Using Patient-Derived Models and Molecular Profiling
- p16 mechanisms in melanoma
- Pancreatic Cyst Fluid miRNOME for Biomarkers of Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
- Pathogenic Mechanisms of CSF3R Mutations in Leukemia
- Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
- Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer
- PCOS, Type II diabetes and ovarian cancer risk
- Pediatric Hematology/Oncology Workforce Diversity and Healthcare Disparities
- Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas
- Peripherally-restricted cannabinoids for cancer and chemotherapy-induced pain
- Personalized therapy for AML patients with a newly identified genetic alteration
- Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
- PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM
- Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS
- Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
- Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays
- PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
- Plasma Generation of Aqueous Chemotherapeutic Solutions
- Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
- PNNL Proteome Characterization Center
- PQ 5 Exploring whole mitochondrial genome of screen detected pre-neoplastic lung lesions by novel approaches
- PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing
- Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping
- Preclinical Models for Cancer Therapeutic Development
- Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer
- Predicting and profiling long-term survival after immune checkpoint inhibition
- Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer Caregivers
- Prevention of Depression in Head and Neck Cancer
- Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell
- PRMT1-mediated metabolic reprogramming in leukemia progression
- Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer
- Prognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic Cancer
- Prospective immune profiling using methylation markers and pancreatic cancer risk
- Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
- Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
- Proteome Characterization Center: A Genoproteomics Pipeline for Cance Research
- Proton minibeams: Overcoming proton beams inability to spare superficial tissues
- Provectors for treatment of ovarian cancer
- Quantitative assessment of the role of collagen alterations in ovarian cancer
- Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment
- Rac1 GTPase in tumorigenesis and progression of pancreatic cancer
- Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy
- Radiotherapeutic Nanoseeds for Internal Radiation Therapy of Unresectable Solid Tumors
- Real-time histopathology for intra-operative tumor margin delineation
- Real-time monitoring of circulating pancreatic tumor cells and clusters
- Receptor-Targeted Neuroendocrine Tumor Imaging with Generator-Produced Cu-62
- Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
- Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
- Regulation of multiple myeloma by S100A9 protein
- Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
- Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate
- Reolysin-based combination therapy in relapsed multiple myeloma
- Repositioning Bazedoxifene as a novel IL-6/GP130 inhibitor for sarcoma therapy
- Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
- Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
- Revealing cancer metabolism via mass spectrometry and isotope tracers
- Risk factors for molecular subtypes of NHL a prospective evaluation
- Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis
- Role of DEAD-box helicase in microRNA biogenesis and Cancer
- Role of EMSY protein complexes in the FA DNA repair pathway
- Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma
- Role of Follicular Dendritic Cells in B lymphoma
- Role of Follicular Fluid Exosomes on Ovarian/Fallopian Carcinogenesis
- Role of GAS41 in human cancer
- Role of histone demethylated LSD1 as an epigenetic dependency in lymphoma
- Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma
- Role of integrin VLA-6 in suppression of bone formation in myeloma
- Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
- Role of KLHL6 inactivation in mature B-cell malignancies
- Role of Metabolic Adaptation in Isocitrate Dehydrogenase I Mutant Glioma
- Role of Nix in pancreatic ductal adenocarcinoma
- Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
- Role of SLC13A3 in Renal Cell Carcinoma
- Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
- SCH: INT: Collaborative Research Intelligent Information Sharing: Advancing Teamwork in Complex Care
- Screening for pancreatic cancer via nanocytology of duodenal cells
- Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia
- Sensitizing Primary Bone Tumors to Radiation Therapy
- SFK-inhibitor enhancement of ATRA-mediated differentiation of APL
- Signaling cascades in cholangiocarcinoma development
- Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology
- SIRT2 Inhibitors for the Treatment of B-cell Lymphoma
- SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia
- Small molecule inhibitors targeting oncogenic drivers of hepatocellular carcinoma
- Smartphone for molecular cancer diagnostic in Africa
- Splicing factors and RNA processing alternations: exploring new players in glioblastoma development
- Stem cell signals in pancreatic adenocarcinoma metastasis and therapy resistance
- Structural basis of chemokine receptor signaling in tumor progression
- Structural Variation in Neuroblastoma
- Suppression of pancreatic tumorigenesis by the PTF1 transcription factor network
- System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs
- Systematic Light Exposure for Fatigue in Stem Cell Transplant Survivors
- Systematic Programmed Illumination (sPI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue During Hematopoeitic Stem Cell Transplantation for Multiple Myeloma
- Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC
- Systems analysis of phenotypic switch in control of cancer invasion
- Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
- Targeted Molecular Imaging of Cell Death in Ovarian Cancer
- Targeted Nanotherapy for Pancreatic Cancer
- Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)
- Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses
- Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richters Transformation (RT)
- Targeting cancer-associated cohesin alterations
- Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
- Targeting CXCR5 for angioimmunoblastic T-cell lymphoma
- Targeting cytokine mediated CREB activation in pancreatic cancer
- Targeting cytokines to the tumor microenivronment using a high affinity single domain antibody to PD-L1
- Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms
- Targeting DYRK1A Modulation of GLI1 for Anti-Tumor Efficacy
- Targeting extracellular matrix-cancer stem cell interactions in pancreatic cancer
- Targeting high fat diet-driven DNA hypermethylation for AML chemoprevention
- Targeting Human Cancers with Hemizygous Deletion of TP53
- Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer
- Targeting insulin receptor splicing for treatment of rhabdomyosarcoma
- Targeting macrophages for immunotherapy in pancreatic cancer
- Targeting Multiple Myeloma with Smac-mimetics and HDAC Inhibitors
- Targeting Neuroblastoma with armed T cells
- Targeting nutrient-sensing pathways in cancer
- Targeting PARP and RAD52 to induce dual synthetic lethality in leukemia patients identified by gene expression and mutation profiling
- Targeting PRL2 phosphatase in acute myeloid leukemia
- Targeting protein-protein interactions of Bmi1 oncoprotein
- Targeting TCA cycle in Brain Tumor Initiating Cells
- Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
- Targeting the Ig-light chains with CAR-T cells in lymphoid tumors
- Targeting the MLL complex in Castration Resistant Prostate Cancer
- Targeting vismodegib-resistant tumors using BH3 mimetics
- Temozolomide Perillyl Alcohol Conjugate as Treatment for Recurrent Malignant Brain tumors
- Testicular effects of modern chemotherapy regimens in osteosarcoma survivors
- TET enzymes as guardians of genome stability
- The 19th International Workshop on KSHV and Related Agents
- The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis
- The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas
- The EDRN Mesothelioma Biomarker Discovery Laboratory
- The effect of statins on B cell dysfunction in HIV infection
- The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma
- The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis
- The impact of aging-associated chronic inflammation on the selection for oncogenic driver mutations in hematopoietic stem cells
- The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations
- The role of AXL-ABL axis in Barretts carcinogenesis
- The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
- The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
- The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development
- The role of KIF2C/AURKA signaling in cilia loss and progression of glioblastoma.
- The role of Lin28/let 7 pathway in Wilms tumor
- The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblastoma
- The Role of LMO2 in the Pathogenesis of T-cell Leukemia
- The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas
- The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
- The role of Neuropilin 1 in Glioma Associated Microglia and Macrophages
- The role of optical biomarkers in endoscopic detection and therapeutic monitoring of gastrointestinal cancer
- The role of PRAME in promoting metastasis in uveal melanoma
- The role of Prrx1 in acinar-ductal metaplasia during pancreatic tumorigenesis
- The role of Sin3B in normal and malignant hematopoietic stem cell functions
- The Role of Suppressor of Fused in Neural Stem Cells and its Implications in Tumorigenesis
- Therapeutic approaches for LKB1-deficient non-small cell lung cancer
- Therapeutic insights through patient derived leukemia xenografts
- Therapeutic strategies for targeting PARP1 in small cell lung cancer
- Therapeutic targeting of glutamine metabolism in MDS
- Therapeutic targeting of Kras-driven Lung Adenocarcinoma
- Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
- Three-dimensional, mechanically tunable scaffold systems to model osteosarcoma heterogeneity and therapeutic response
- Toward identification of a family of novel NF-kB inducers
- Towards the automation of MR spectroscopic imaging in patients with glioblashoma
- Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
- Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis
- Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer
- Transforming the diagnosis and care of patients with CTCL using TCR sequencing
- Transporters and hematopoietic toxicity
- Treatment of glioma with nanocombretastatin with MRI monitoring
- TSPO Ligands for Cancer Imaging
- TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions
- Tumor Genetics and Response to Checkpoint Blockade in Melanoma and Ovarian Cancer
- Tumor subtypes and therapy response in pancreatic cancer
- Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
- Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity
- Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
- Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis
- Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell
- Understanding Esophageal Adenocarcinoma Progression Using Inflammatory and Neoplastic Extracellular Matrix Hydrogels
- Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
- Understanding the mechanism of H3K9 HMT mediated suppression of melanoma
- Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
- Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
- Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia
- Urine DNA Kit for monitoring HCC recurrence
- Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
- Using markers to improve pancreatic cancer screening and surveillance
- Using the Collaborative Cross for Model Studies of Intestinal Cancer
- Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression
- Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
- Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes
- Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
- Validation of FOXM1 as a new therapeutic target in high-risk myeloma
- Validation of Methylated Vimentin as a Diagnostic Test for Barretts Esophagus
- Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
- WDR5 as a Critical Co-Factor for MYC
- Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?
- Web-based Physical Activity Intervention for Children with ALL
- Yap and beta-catenin interactions in liver: Implications in Pathophysiology
2015
- (PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
- (PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
- (PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
- (PQC2) Localization as a determinant of cancer dormancy
- (PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance
- (PQC3) Immunological Basis of Health Disparities in Multiple Myeloma
- 18th International Workshop on Kaposis sarcoma herpesvirus and related agents
- 2015 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Seminar
- 4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
- 4th International RASopathies Symposium
- 5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancers
- A biochemical companion diagnostic platform to measure kinase inhibitor pharmacodynamics in leukemia
- A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatric solid tumors
- A cell-based liquid biopsy approach for early pancreatic cancer detection
- A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
- A Creative Integration of Omega-3 Fatty Acids into Pancreatic Cancer Chemotherapy
- A differentiation-based mechanism limiting pancreatic tumor initiation
- A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
- A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3
- A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
- A new energy restriction mimetic that targets pancreatic cancer
- A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
- A novel combination approach for pancreatic cancer prevention
- A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia
- A novel miR-198 replacement therapy for pancreatic cancer
- A novel mouse model to identify biomarkers of IPMN formation and progression
- A novel strategy to overcome resistance in Temozolomide-Refractory Glioblastomas
- A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
- A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD
- A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
- A Post-Visit Patient Portal Tool to Promote Colorectal Cancer Screening
- A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
- A role for macrophage phenotype in regulating metastasis in pancreatic carcinoma
- A scalable platform for target validation in GEMM models of gastrointestinal malignancies.
- Aberrant activation of HGF/MET signaling as a therapeutic target in AML
- Adding patient and provider viewpoints to rectal cancer practice variation data
- Addressing Tobacco Use Disparities through an Innovative Mobile Phone Intervention: The textto4gosmokelesstobacco
- Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
- ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER
- Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
- Analysis of Racial Disparities in HCC by Systems Metabolomics
- Apoptotic Proteins as Molecular Modulators of Stem Cell Fate
- Aptamers as Proteomic Tools for Pancreatic Cancer Biomarker Identification
- Arf6 inhibitors for the treatment of uveal melanoma
- Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells
- ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development
- Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma
- Beneficial effects of Honokiol against liver cancer
- Biologic Markers of Chronic Graft vs. Host Disease Therapeutic Response
- Biomarkers in pediatric versus adult myelodysplastic syndromes
- Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
- Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
- BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
- BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
- Breaking immune tolerance to Survivin in Multiple Myeloma
- Cancer Gene Discovery to Identify Targetable Targets
- Cancer imaging phenomics software suite: application to brain and breast cancer
- Cancer Initiating Cells and Treatment Resistance
- Cancer Risks in Shipyard Workers Exposed to Asbestos and Welding Fumes
- Career Development and Increasing Diversity in Pediatric Hematology/Oncology
- Cdk5 signaling in ICN1-induced T Cell Leukemogenesis
- Cell-free tumor DNA in cerebral spinal fluid decodes tumors of the central nervous system
- Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma
- Characterization of breast cancer dormancy in bone
- Characterization of GATOR1 signaling to mTORC1 and its role in cancer
- Characterization of mTOR signaling during early stages of gliomagenesis
- Characterization of replication-mediated DNA damage in B lymphocytes
- Characterization of the LGL Leukemia Virus (PQ 12)
- CHARACTERIZATION OF THE MOLECULAR INTERPLAY BETWEEN HOXA9 AND OGT IN ACUTE LEUKEMIA
- Characterization of virus-specific CD8 T cell responses in Merkel Cell Carcinoma
- Characterizing functional targets of a non-coding RNA oncogene, SNORA42
- Characterizing MSI2 in leukemia
- CHEMOPROTEOMICS PROFILING OF PARTHENOLIDE IN HUMAN GLIOBLASTOMA
- Chemosensitizing Hypoxic Multiple Myeloma With Tunable, Long-Lived Oxygen Carriers
- Childhood Leukemia International Consortium Scientific Annual Meetings
- Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML)
- Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach
- Clinical efficacy of the antitumor agent ONC201 in GBM
- Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors
- Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation
- Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma
- Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV
- Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses
- COG Biospecimen Bank
- Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
- Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma
- Compact Representations of Dynamic Liver MRI
- Consequence of collective cell invasion in glioblastoma
- Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
- Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center
- Control of GVHD and Leukemia Relapse by Targeting Cell Metabolism
- Controlling Esophageal Cancer: A Collaborative Modeling Approach
- Convertible MRI contrast signaling delivery and release of anti-glioma nano-drug
- CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS
- Crosstalk Between Platelets and Brain Tumor Initiating Cells in Glioblastoma
- CSF2 receptor mediated actions in t(8;21) leukemia
- Cytokine- and Satellite Cell-mediated Muscle Disease Promotion
- Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy
- Deciphering Links Between Inflammation and Cancer with IMP-1 Inhibitors
- Deciphering SIRT6-dependent metabolic liabilities in Pancreatic cancer
- Decoding and targeting the PI3K-mTOR signaling network in cancer
- Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma
- Defining the functions of extracellular shed vesicles in cancer progression
- Defining the Role for A Lipid Kinase in the Progression of Pancreatic Cancer
- Defining the role of ERK1 and ERK2 in Pancreatic Cancer
- Defining the role of mutant XPO1 in chronic lymphocytic leukemia
- Defining the role of RBM10 in RNA processing and tumor suppression
- Detection of 5-hmC as a Novel Screening Biomarker for Pancreatic Cancer
- Detection of major HBV integration sites in urine as a biomarker for HBV-associated liver cancer
- Determining the mutational landscape of circulating multiple myeloma cells
- Developing a Screen for Novel Therapies with Reprogrammed Pancreatic Cancer Cells
- Development and Optimization of an Analytical Chemical Separations Technique to Analyze E3 Ligase Activity in Single Cells
- Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era
- Development of a Minimally Invasive Surgical Device for the Treatment of Esophageal Cancer
- Development of a Novel Inducer for EBV Lytic Therapy
- Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors
- Development of an ADC against Pancreatic Cancer
- Development of mosaic mouse models of HCC for genetic interspecies inference
- Development of novel lung cancer therapeutics targeting the DNA damage response
- Development of novel targeted agents in pancreatic cancer
- Development of Nuclear Auger Emitters for Targeted Radiotherapy
- Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor
- Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis
- Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring
- Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia
- Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
- Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML
- Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
- Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
- Discovery of Synthetic Lethals in Pan-Cancer Genomic Data Using Boolean Methods
- Disruption of circadian rhythm in hypoxia
- Disruption of the Host DNA Damage Response by Hepatitis C Virus
- Dissecting ALK4 Function in Cancer Progression
- Dissecting CRBN-substrate interactions in the mechanism of lenalidomide
- Dissecting Genetic and Epigenetic variation in the Cancer Regulome
- Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
- Dissection of Pten-regulated signals in hepatopathogenesis
- Distribution, regulation and function of a novel lysine PTM in metabolic disease
- Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?
- Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?
- Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
- Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers
- Dual recombinase models of pancreatic cancer
- Dual targeting of XPO1 and BTK in B cell malignancies
- Dynamic Complexity of Brain Tumor Stem Cells
- DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
- Early Phase Clinical Trials in Imaging and Image-Guided Interventions
- ECM geometrical and mechanical properties modulate RTK signaling
- ECOG-ACRIN Biorepositories to Support NCTN
- Effector T Cell Trafficking in Ovarian Cancer
- Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
- Efficacy of PDI inhibitors in glioblastoma
- Elucidating and targeting the molecular foundations of IDH mutant glioma
- Elucidating Mechanisms of Resistance to Src Inhibition in Thyroid Cancer
- Elucidating the role of microRNAs in the initiation of multiple myeloma
- Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer
- Employing mouse models to translate early detection of pancreas cancer
- Endoenteric Balloon Coils for Improved MR Imaging of the Pancreas and Upper GI Tract
- Endoplasmic reticulum stress and oncoviral therapy
- Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
- Engineering therapeutic and diagnostic proteins for tumor biomarker mesothelin
- Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
- Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
- Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia
- Epidemiology of Ovarian Cancer in African-American Women
- Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma
- Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
- Epigenetic Regulation of Neuroblast Differentiation
- Epithelial-stromal cross-talk in esophageal inflammation and carcinogenesis.
- Esophageal cancer in West Kenya
- Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL
- Exosome-Dependent Trafficking of Epstein-Barr Virus LMP1
- Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
- Exploiting Notch inhibition as a mechanism to overcome resistance in ccRCC
- Exploring a new therapeutic approach through targeting epigenetic enzymes in ALL
- Exploring the oncogenic potential of human APOBEC3 cytosine deaminases
- Fas protects cancer stem cells from death
- FASEB SRC on Helicases and Nucleic-Acid Based Machines: From Mechanism to Insights into Disease
- FAST TRACK: IND Enabling Studies for Oral Cancer
- Feasibility of Molecular Cytology for the Management of Barretts Esophagus
- FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer
- Finding Novel Pancreatic Cancer Oncogenes Using an Innovative 3D Culture System
- Functional dissection of oncogenic enhancers
- Functional imaging-directed adaptive therapy of head and neck cancer
- Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
- Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis
- Gene-engineered adoptive T cell immunotherapy of GBM
- Generation and characterization of adduct-specific anti cisplatin DNA antibodies
- Generation of NKT cells from adult stem cells for adoptive immunotherapy
- Genetic analysis of ras mutation specificity in skin and lung cancer
- Genetic and Environmental Risk of Liver Disease/Cancer among Mexicans
- Genetic evolution of glioblastomas during radiation and temozolomide therapy
- Genetic Framework and Molecular Mechanism of Fanconi Anemia
- Genetic Predictors of Response to mTOR inhibitors in advanced Renal Cancer
- Genetic susceptibility to acute lymphocytic and myeloid leukemia
- Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations
- Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy
- Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)
- GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
- Genomic and transcriptomic characterization of atypical carcinoids of the lung
- Genomic studies for understanding etiology of esophageal adenocarcinoma
- Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection
- Glutamine catabolism in c-Myc driven liver tumor development
- Glycan control of stem cell-associated pathways in pancreatic cancer
- gp130 as a novel therapeutic target in ovarian cancer
- Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
- Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
- HAUSP inhibitors in p53-wild type and p53-mutant tumors
- Heme oxygenase-1 as a tumor factor and therapeutic target for Kaposi sarcoma
- Hepatic Stellate Cells and Liver Cancer
- HHV-8 vIRF interactions in the context of infection
- High fat diet stimulates pancreatic cancer through the actions of Cholecystokinin
- High Specificity MicroRNA Microarray Analysis without PCR for Cancer Screening and Research
- High-throughput immunoglobulin gene sequencing as a peripheral blood minimal residual disease assay to predict post-transplant relapse risk in multiple myeloma
- HIV-1 Vif in AIDS-Related Malignancies
- How do genome alterations cause human lung cancer?
- How Does FLT3 Mutation Regulate Myeloid Differentiation in Acute Myeloid Leukemia
- HTS for Identification of Novel Inhibitors of Pyk2 Activity
- iDDS probes detecting IDH mutants in brain cancer
- Identification and development of inhibitors of the Hippo-Yap pathway
- Identification and Targeting Therapy Resistant Osteosarcoma
- Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
- Identification of Cell Surface Markers for Risk Stratification of Barretts Esophagus Patients
- Identification of Loci Modifying Atm Lymphomagenesis
- Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
- Identification of synthetic lethal interactors in pancreatic cancer
- Identifying BRCA1 protein variants that provide resistance to therapy
- Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM
- Identifying microRNA Targets for Early Detection of Myeloproliferative Neoplasms
- Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
- IDO2 Targeting in Pancreatic Cancer
- IGF-II-Based Approach to Therapy for Pancreatic Cancer
- Illuminating molecular targetable pathways in HNSCC
- Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
- Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
- Immunotherapeutic targeting of the Glioblastoma Mutanome
- Improving BTK Directed Therapy for CLL
- Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway
- Improving Radiation Therapy For Pancreatic Cancer
- Improving risk allocation and developing novel therapies for children with T-ALL
- In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
- Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
- Inhibiting MYC for the Treatment of Multiple Myeloma
- Injectable Implants for Increased Tumor Treatment Volume Using Pressure Driven Diffusion
- Innovative solutions to spatial uncertainty in geocoding
- Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
- Integrated Systems for the Analysis of Circulating Multiple Myeloma Cells (CMMCs)
- Integrative Analyses to Identify Pancreatic Cancer Susceptibility Genes
- Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
- Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue
- Interrogation of MLL2 as a tumor suppressor gene in lung cancer
- Intratumoral Heterogeneity and Tumor Evolution in Lymphoma
- Investigating a Novel Glutamine Metabolism Pathway in Pancreatic Cancer
- Investigating non-coding mechanisms of functional dysregulation in neuroblastoma
- Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
- Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
- K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
- KS-Detect: A solar-powered and smartphone integrated instrument for point-of-care diagnosis of Kaposis sarcoma
- Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions
- Lassa-VSV targets and kills glioma, and is not neurotoxic
- Leukemia-promoting effects of microbiota
- Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management
- Leveraging GxE interaction to understand pancreatic cancer and altered metabolism
- Leveraging in vivo models to identify epigenetic vulnerabilities in leukemia
- Ligase III regulates survival from crisis induced by gradual telomere shortening
- Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
- Liver Cancer Risk with rAAV Gene Therapy
- Long non-coding RNAs in hematopoiesis and blood malignancy
- Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions
- Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance
- Magnetic Micelles for Catheter-Directed Sorafenib Delivery to Liver Tumors
- Markers of Cognitive Decline During Treatment for Childhood ALL
- Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers
- Maximal MYC control using dual PI-3K/BRD4 (kinase/epigenetic) inhibitors
- MDSCs in Ovarian Cancer
- Mechanism of tumor promotion by the H3K9 histone demethylase KDM3A in Ewing Sarcoma.
- Mechanisms and Function of Suppressed RAG Expression by DNA Double Strand Breaks
- Mechanisms for sensitivity to PARP inhibitors in cancers involving ALT NHEJ
- Mechanisms of obesity-induced hepatocarcinogenesis
- Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
- Mechanisms of regulation by RNA in acute myeloid leukemia
- Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
- Mechanisms of Tumorigenic Transformation of Barretts Esophagus
- Mechanisms underlying cytokine-induced memory-like natural killer cell differentiation and maintenance.
- Mechanistic and Informatics Based Analysis of STAT1 Actions in Pancreatic Cancer
- Merkel cell polyomavirus infection, DNA damage response and cancer
- Merkel cell polyomavirus T antigens in tumorigenesis
- METABOLIC DRIVERS OF LUNG CANCER INITIATION, PROGRESSION AND THERAPY RESPONSE
- Metabolic pathways in leukemia
- Metabolic Regulation in Leukemia-Initatiating Cells
- Method to analyze X-chromosomal genetic data
- Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
- Microenvironmental Regulation of Glioblastoma Angiogenesis via CHD7
- MicroRNAs mediating Notch signaling in lung adenocarcinoma
- Misassembled BAF complexes in human cancer: structural and functional consequences
- Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer
- Modeling Neoplastic Progression in Barretts Esophagus
- Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
- Modified MIS Production & Process Development for Preclinical & Clinical Studies
- Modulation of cancer specific transcriptional factors with small molecules
- Modulation of MicroRNAs with Xenobiotics to Target c-Myc
- Modulation of the Immune System as a Strategy to Treat EGFR Mutant Lung Adenocarcinoma
- Molecular and Therapeutic Basis of Morphometric Aberrations in Brain Tumors
- Molecular determinants of PARP inhibitor sensitivity in 11q-deleted malignancy
- Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis
- Molecular Mechanisms of G5-7 Allosteric Inhibition of Jak2
- Molecular mechanisms of myeloid suppressor genes on chromosome 5
- Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
- Molecular Pathogenesis of Acute Myeloid Leukemia
- Molecular understanding of cytokine-Ras signals in leukemic bone marrow
- Monitoring disease progression in follicular lymphoma with next-gen sequencing
- Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy
- MR-HIFU induced drug delivery for pancreatic cancer treatment
- MRI-Guided Irreversible Electroporation Ablation for Liver Tumors
- MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors
- Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy
- Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics
- Multiplexed imaging of biliary intra-epithelial neoplasia
- Multiplexed Multi-Modal Endoscopic Imaging of Cancer Biomarkers
- Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
- Murine Models on SALL4 in Hepatocellular Carcinoma
- Musashi-mediated control of pancreatic cancer growth and progression
- Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma
- Mutations in Runx1 and epigenetic modifiers cooperate in leukemogenesis
- MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma
- MYC is a critical downstream effector in KRAS-driven pancreatic cancer
- MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
- Myc-induced pathways in B cell lymphoma initiation and survival
- Myelodysplastic Syndrome Target Identification and Validation
- Nano-cocktail overcomes multidrug-resistance for ovarian cancer therapy
- Nanoparticles for selective and combinatorial delivery of siRNA to brain cancer
- Nanoplasmonics-based molecular analysis tool for molecular biomarkers of cancer
- Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy
- Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers
- Neuroimmune Mechanisms of Cancer-Related Symptoms in Oral Squamous Cell Carcinoma
- Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
- New Therapeutic Targets in AML
- New transgenic animal model to study pancreatic cancer
- NKT cells with chimeric antigen receptors
- Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer
- Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM
- Novel BPTES Analogs for the Treatment of Pancreatic Cancer
- Novel immunological biomarkers ovarian cancer prognosis
- Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
- Novel nano-plasmonic technology for quantitative analysis of cancer exosomes
- Novel role of compensatory proliferation in human brain tumor
- Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus
- Novel Strategies to Target Leukemia-Stromal Interactions
- Novel targeted therapies for isocitrate dehydrogenase mutant cholangiocarcinoma
- Novel Targeted Therapy for AML
- Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
- Novel therapeutics of targeting mTOR pathway in T-cell leukemia
- NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION
- Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
- Nutritional Control of Cancer Cell Function by Amino Acids
- Occupational Pesticide Use and Risk of Lymphoid Cancers
- Oncogenic Function of Ca2+ Channel Orai1 in Esophageal Carcinogenesis
- Oncolytic Herpes Simplex Virus Interactions with Glioblastoma Stem Cells
- Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
- Oncolytic virotherapy and immunotherapy in the treatment of brain tumors
- Online monitoring and image-guided treatment of chemoresistant micrometastases
- Open source diffusion MRI technology for brain cancer research
- Optimization and Efficacy of Covalent Ire-1 RNase Inhibitors in CLL
- Optimization of a clinical stage nanoparticle drug delivery platform
- Optimization of radiofrequency ablation with electrically conductive particles
- Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
- Origin and Lineage of Differentiation of Kaposis Sarcoma
- Origins of Ovarian Carcinoma
- Osteosarcoma: Patient Derived Xenograft Preclinical Testing
- Ovarian Cancer Chemoprevention
- Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing
- P53 survival target DDR1 kinase in DNA damage response and carcinogenesis
- p53-Mediated Tumor Immune Surveillance
- Parental Exposure to High Fats Diets and Risk of Pancreatic Cancer in the Offspri
- Passenger mutations due to activation-induced deaminase as biomarkers in lymphoma
- Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk Neuroblastoma
- Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes
- Pediatric Cancer Interdisciplinary Team Training for Regoaling CARE Discussions
- Pediatric Cancer Salvia Biorepository
- Pediatric Preclinical Testing Consortium
- Pediatric Preclinical Testing Consortium – Leukemia
- Pediatric Preclinical Testing Consortium: Coordinating Center
- Pediatric Preclinical Testing Consortium: Research Programs Non-CNS (U01)
- PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer
- Pharmacological Ascorbate as a Radiosensitizer in Pancreatic Cancer
- Pharmacological Blockage of XBP-1s Expression in Cancer
- Phosphatase activation as therapeutic strategy for Chronic lymphocyic leukemia
- Phosphoproteomic signatures for early detection and stratification of AML
- Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
- PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia
- Preclinical Development of BILT, a Next-Generation Immunotoxin Therapy for CTCL
- Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
- Predicting clinical outcome in individuals with small CLL B cell clones
- Pre-IND study of PMT-254, a pan-FLT3 inhibitor for the treatment of FLT3 driven cancers.
- Prenatal stress and neuroblastoma development – is there a link?
- Prevention of solar UV-induced skin cancer by targeting LTA4H
- Pro- and anti-phagocytic signals on pancreatic cancer regulate tumor macrophages
- Problem-Solving Skills Training for Clinicians Providing Psychosocial Care in Pediatric Oncology
- Profiling Circulating miRNA Without PCR for Early Detection of Pancreatic Cancer
- Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission)
- Prototype optical device for image guided surgery with panitumumab-IRDye800
- Quantifying and Characterizing the shared genetic contribution to common cancers
- Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma
- Radioactive Stents for Brachytherapy of Esophageal Cancers
- Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies
- Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus
- Rare Disease Research Training Program
- Reactivation of embryonic growth programs in liver cancer
- Real-time Tumor Localization and Guidance for Radiotherapy Using US and MRI
- Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
- Reducing risk of Anthracycline-related heart failure after childhood cancer
- Regulation of cancer cell metabolism and growth by the pancreatic tumor stroma
- Regulation of Death Ligand-Induced Killing
- Regulation of glioma stem cell malignancy by neural activity in the tumor niche
- Regulation of pancreatic ductal adenocarcinoma progression by Hnf4a
- REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
- REGULATORY MECHANISMS OF HOX GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA
- Repositioning Bazedoxifene as a novel IL-6/GP130 inhibitor for sarcoma therapy
- Reprogramming the pancreatic tumor microenvironment with immunotherapy
- Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle
- Resting-state fMRI for Language Mapping in Brain Tumor Patients
- RETARGETING AGENTS TO TREAT AML
- Retargeting FDA Approved Anticancer Liposomal Drugs to Cancer Stem Cells
- RIP1/3 Kinases as New Targets in Malignant Mesothelioma
- Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
- Role of desmoglein 1 in regulating redox and growth factor signaling in head and neck cancer
- Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer
- Role of estrogen receptor-alpha in ovarian cancer
- Role of FOXP1 and WNT signaling in B-cell Lymphoma
- Role of GSK3beta Subcellular Localization in AML Stemness
- Role of inflammatory microenvironment in Helicobacter-induced gastric cancer
- Role of LMO1 in Neuroblastoma Initiation and Maintenance
- Role of lncRNAs in Clinical Heterogeneity of Early Stage IGHV Unmutated CLL
- Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis
- Role of PTPN1 in myeloid malignancies
- Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy
- Role of the Mre11 complex in the maintenance of genome stability
- Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma
- Role of Type III TGF-beta Receptor Shedding in Lung Cancer Initiation and Progression
- ROS-targeted therapy for pancreatic cancer
- Salivary Metabolite Biomarkers for Diagnosing Nodal Metastasis in Oral Cancer
- Scalable Cancer Genomics via Nanocoding and Sequencing
- Scutellaria Baicalensis Targets HIF-1(alpha) in Cancer
- See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization DrugDelivery
- Selective RET Kinase and Its Mutant Inhibitors for the Treatment of Medullary Thyroid Cancer
- SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA
- Serum Biomarkers for Adrenocortical Cancer
- Single cell cytokine analysis of circulating malignant hematopoietic cells
- Single cell growth assay for residual cells in acute lymphoblastic leukemia
- Small molecule CXCR4 modulators as molecular probes for studying AML
- Somatic Engineering-based Models of Pancreatic Cancer
- Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma
- Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
- Stress response networks in cancer: systematic mapping and therapeutic potential
- Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy
- Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes
- Study of biomarkers in ovarian cancer: modulation by activity & diet intervention
- Subharmonic Contrast Ultrasound for Improved Characterization of Adnexal Masses
- SWOG Biospecimen Bank
- SYNERGIZING PRO-APOPTOTIC AND CAR-T CELL IMMUNOTHERAPY FOR MANTLE CELL LYMPHOMA
- Systemic EGFRvIII-targeted bispecific antibody as immunotherapy for glioblastoma
- T cell TGF-beta signaling as a therapeutic target for pediatric brain tumors
- Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML
- Targeted- and timed-releasing nanotherapeutics against leukemia stem cells
- Targeted electric field therapy for malignant infiltrative glioma
- Targeted Radiation Therapy for Pancreatic Cancer
- Targeted Therapy for Leukemia
- Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
- Targeting alternative transcription/translation of RUNX1-ETO fusion gene
- Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
- Targeting BRCA Deficient Cells for Killing
- Targeting Cancer Stem Cells in Multiple Myeloma Therapy
- Targeting CD37 and elucidating its role in B-cell malignancy
- Targeting CD44-mediated calcium signaling for the treatment of relapsed myeloma
- Targeting Cdc42 for bone marrow transplant therapies
- Targeting Chk1 in Acute Myeloid Leukemia
- Targeting defective DNA repair for the prevention of BRCA1-associated cancers
- Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma
- Targeting Granzyme B to Separate GVH from GVL Responses
- Targeting Kras in Pancreatic Cancer
- Targeting Mesenchymal Stem Cells in Head and Neck Cancer
- Targeting MLL3 histone methyltransferase
- Targeting osteoblasts to inhibit AML
- Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1
- Targeting PAK4 for Overcoming Drug Resistance in Pancreatic Cancer
- Targeting Pancreatic Cancer with Novel Mnk-eIF4E and AR Modulating Agents
- Targeting PHD2 in Pancreatic Cancer
- Targeting PKM2-InsP3R interaction to treat AML
- Targeting sphingosine kinase 2 for the treatment of multiple myeloma
- Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
- Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer
- Targeting Tumor Suppressive Pathways for Cancer Therapy
- Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer
- TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells
- TERT Promoter Mutations in Thyroid Cancer
- The adaptive kinome in pancreatic cancer
- The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer
- The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle
- The coding genome of HIV-associated plasmablastic lymphomas in South Africa
- The derivation of pituitary cells from human ES cells
- The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
- The function of cyclin C in tumorigenesis
- The genetics of hepatosplenic T cell lymphoma
- The genomic pathogenesis of Follicular Lymphoma
- The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma
- The impact of chromosome 17p lesions on leukemogeneis and therapy response
- The Interaction of Autophagy and BRAF Mutations in Brain Tumors
- The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
- The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome
- The Molecular Functions of APE1 in Barretts Tumorigenesis
- The NYU Womens Health Study
- The Ohio State University Pancreatic Disorders Network (OSU-PDN)
- The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
- The Role of Cancer Associated Fibroblasts in Pancreatic Tumor Progression
- The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma
- The Role of DDX41 in the Spliceosome and Myeloid Neoplasia
- The role of DYRK1A in regulation of mTOR
- The role of Galpha13 signaling in development and dissemination of lymphoma
- The role of Jmjd1c in normal and leukemic hematopoiesis
- THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS
- The role of Mtss1 in Hedgehog-mediated intestinal cancer stem cell function
- The Role of post-translational activation of Myc in pancreatic cancer
- The role of PRDM1 in epigenetic regulation and tumor suppression
- The role of PRDM16 in Leukemia
- The role of RHOA G17V mutation in peripheral t-cell lymphomas
- The Role of Shp2 Phosphatase Activity in FLT3-ITD+ Acute Myeloid Leukemia
- The role of Sirt2 in haptocarcinogenesis
- The role of stromal APC haploinsufficiency in colorectal tumorigenesis
- The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors
- The role of the LZTR1 ubiquitin ligase in stem cells and cancer
- The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
- The role of wild-type KRAS in the context of tumor profession and metastasis
- The role of ZEB1 mutations in cutaneous T cell lymphoma
- The Significance of Isocitrate Dehydrogenase Mutations in Gliomas
- The SMYD3-ERK5 signaling module in pancreatic cancer
- The Sox9/NFIA Transcriptional Network In Malignant Glioma
- The St. Jude Lifetime Cohort
- The Therapeutic Potential of Targeting MYC Activity in Renal Tumorigenesis
- The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia
- The Tumor Suppressor Role of SMARCA4 in SCCOHT
- The Use of Novel Peptide Probes to Study Proteasome Regulation by Src Family Kinases in Diffuse Large B-cell Lymphoma
- Theranostic nanoparticles for dual modality cancer therapy
- Therapeutic Exploitation of Mutant BRAF for Astrocytoma
- Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec Assay
- Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
- Therapeutic Targeting Agents for Ovarian Cancer
- Therapeutic Targeting of Malignant Glioma Stem Cells
- Therapeutically Exploiting a Newly Isolated Neural-like Stem Cell Against GBM
- TissueCypher Testing for Risk Assessment in Barretts Esophagus
- Tissue-specific tumor suppressor effects of p53
- Translocations And Their Widespread Impact on Gene Regulation
- Treating pancreatic cancer with Listeria-32P
- Treatment of glioblastoma using chain-like nanoparticles
- Triad1 regulates myelopoiesis and functions as a leukemia suppressor
- Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
- Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
- Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
- Tumor Suppressor Localization and Function at the Peroxisome
- Tunable Microchip Sorting of BRCA1 Nuclear Assemblies
- Two phospho-compounds for pancreatic cancer prevention
- U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
- Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
- UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
- Underlying Mechanisms in Angiosarcoma
- Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
- Understanding EGF receptor activation by growth factors and oncogenic mutations
- Using Adductomics to Characterize Exposures to Carcinogens
- Validating a mouse model of ovarian cancer for early detection through imaging
- Validating the eCyPA/CD147 signaling complex for myeloma therapy
- Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes
- Validation of pancreatic cancer biomarkers in large prospective cohorts
- Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma
- Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color Single Particle Tracking and Peptidomimetic Inhibition
- Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
- Viral Non-Coding RNAs and Cell Transformation
- Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
- ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
2014
- (PDQ5)Integrated Genetic and Epigenetic Prognostication for Acute Myeloid Leukemi
- (PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
- (PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
- (PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
- (PQA2) Impact of obesity on endogenous mutational hotspots
- (PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
- (PQB-2) Driver vs. passenger epigenetic events in Ewing sarcoma
- (PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
- (PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
- (PQB-3) Driver gene-induced inflammation in pancreatic cancer development
- (PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation
- (PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
- (PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
- (PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field Cancerization
- (PQC5) MRI of magnetically labeled immune/stem cells for early tumor detection
- (PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
- (PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
- (PQD2) Molecular Basis for the Chemosensitivity of Testicular Germ Cell Cancers
- (PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
- (PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
- (PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
- (PQD4) MicroRNA Dysregulation in Field Effect is a Prerequisite for Tumorigenesis
- (PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
- (PQD5) Avatar-directed Treatment for Ovarian Cancer
- (PQD-5) Patient derived orthotopic xenograft models for drug response prediction
- (PQD5)Biomaterials-based Adaptive Tumor Microenvironments for In Vitro Drug Scree
- 3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
- 99mTc-Tilmanocept for Sentinel Lymph Node Biopsy in Cervical Cancer Surgeries
- A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
- A longitudinal assessment of frailty in young adult survivors of childhood cancer
- A molecular mechanism whereby metformin protects against liver cancer
- A Mouse Model of DNMT3A-Associated Hematologic Malignancy
- A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
- A Novel Agent with Dual Functions to Treat Head and Neck Cancer
- A novel antibody drug conjugate for metastatic renal cancer treatment
- A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep
- A Novel Epigenetic Circuit in Acute Leukemia
- A novel functional genomic pipeline for target identification in sarcoma
- A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
- A novel mediator of obesity associated hepatocellular carcinoma (HCC)
- A Novel Multimodality Immune Based Platform in Advanced Mycosis Fungoides
- A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
- A novel regimen to target both pancreatic cancer k-ras and antiapoptotic proteins
- A novel role for pml bodies in leukemic transformation
- A novel soluble receptor-based therapy for Kidney Cancer
- A novel targeted delivery system for cancer treatment and diagnosis
- A novel targeted therapy for HNSCC based on a novel activity of cetuximab
- A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma
- A phase i trial combining iv fenretinide and iv safingol to target overproduction
- A protein based strategy to reverse bone marrow failure resulting from radiation
- A radiotherapeutic for breast cancer brain metastases
- A role for notch in self renewal in embryonal rhabdomyosarcoma
- A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
- A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
- Actin dynamics as a therapeutic target for bcr-abl-positive acute lymphoblastic leukemia.
- Active Viral Hepatitis Diagnostics to Support Prevention/Treatment of HCC
- Adaptable hydrogel platform to study pancreatic cancer
- Advanced Training in Urologic Oncology
- ALK Rearrangements in Aggressive Thyroid Cancer
- Altered microrna as a biomarker for the onset of obesity related womens cancers
- Alternative End-Joining in DNA Repair and Chromosomal Translocations
- An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
- An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
- An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer
- An innovative in situ cell reprogramming technology for cancer treatment
- Analysis of CTCs for Early Prediction of Response to Treatment in RCC
- Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
- Application of Boolean Networks to discover stem and progenitor cells
- ARID5B and disparities of childhood leukemia
- Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
- Assay Development for NSD1 Methyltransferase Inhibitor Discovery
- Assessment of hypercoagulability in cancer patients using sonorheometry
- Assessment of microvessel density and tumor proximity for prognosis of cancer
- Autoimmune Conditions, Genetic Variations, and Lymphoma Etiology
- Autophagy as a microenvironmental regulator of tumorigenesis and resistance
- Autoregister: a system for enhancing the accuracy of tumor change detection
- B cell repertoire molecular platform for antibody drug discovery
- Bayesian approaches for missingness and causality in cancer and behavior studies
- Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
- Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer
- Blood-based Angiome Profiling to Direct Bevacizumab Therapy in Ovarian Cancer
- Bridging the gap from discovery to survival in the interlymph consortium
- Building upon a tradition of excellence. The NCTN at Indiana University
- Cathepsin inhibitors for treatment of breast cancer induced bone pain
- Cd4 t cell response to bcr-abl positive leukemia
- Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma
- Cell line panel profiling for discovery of multiple myeloma therapeutics
- Cellular and Biologic Origins of CLL
- CendR peptide-mediated enhancement of systemic oncolytic herpes virotherapy
- Central Neck Dissection in Patients with Clinical Node Negative Thyroid Cancer
- CERT Imaging of Cancer
- Characterization of a non-canonical role for Foxo1 in B cell lymphoma
- Characterization of Drug Survival by Pancreatic Cancer Cells in vitro and in vivo
- Characterization of Epigenetic Targets in Prostate Cancer
- Characterization of non-competitive proteasome binding
- Characterizing the genomic architecture and molecular mechanisms driving the form
- Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies
- Chemical optimization of a novel class of usp7 inhibitor for cancer treatment
- Chemically Programmed Bispecific Antibodies for Cancer Therapy
- Chemically programmed bispecific antibodies for cancer therapy
- Chemofilter: a novel catheter device to enable high-dose chemotherapy treatment
- Childrens Oncology Group Statistics and Data Center
- Chronic stress in the absence of blm induces metabolic alterations
- Clinical development of cancer-specific MRS biomarkers in malignant gliomas
- Cll mutation detection and monitoring from blood using ac electrokinetics
- Clustered semi-competing risks analysis in quality of end-of-life care studies
- Cog nctn network group operations center
- COG NCTN Solid Malignancy Integrated Translational Science Center
- Collaborative Human Tissue Network (CHTN)
- Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
- Conferring in vivo metabolic resistance to a highly selective anti-AML agent
- Contractor: mayo clinic; dunns: 006471700; pilot study of egfr inhibition with erlotinib in cirrhosis to inhibit firbrogenesis and prevent hepatocellular carcinoma hhsn261201200042i; task order hhsn26
- Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy
- Cooperating Pathways in Gliomagenesis
- Correcting aberrant splicing of the human cd22 gene
- Cytotoxicity of MLN4924 in Acute Myeloid Leukemia
- Deciphering the pathogenesis of pediatric high-grade gliomas
- Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer
- Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
- Defining the Role and Mechanism of Pak1 in Supporting Pancreatic Cancer
- Defining the Tn-glycoproteome of in situ colorectal tumors and mechanisms of Tn e
- Descriptionpatterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015line item #: 1
- Detection of cox-2-expressing bladder cancer by fluorocoxib a
- Determining the kinetics and mechanism of pancreatic tumor regression following genetic deletion of PI3K p110a
- Determining the role of CUX1 in myeloid neoplasia
- Developing an Anti-sialyl-Lewisa Diabody for ImmunoPET Imaging of Pancreas Cancer
- Developing CRM1 inhibitors in AML
- Developing Novel STAT5 Protein Inhibitors for treatment of leukemias
- Development and Application of Selective Covalent Cdk7 Inhibitors
- Development of a coiled-coil therapeutic for non-hodgkin’s lymphoma
- Development of a Small Molecule Inhibitor for KSHV LANA
- Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer
- Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers
- Development of Integrated Analysis Methods and Applications to TCGA data
- Development of integrated analysis methods and applications to tcga data
- Development of transporter targeted platinum drugs for pediatric tumor
- Diagnostic assays for ovca recurrence using paraneoplastic antigens and epitopes
- Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells
- Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia
- Discovering genomic rearrangements under selection in serious ovarian cancer
- Discovery of Homologous Recombination DNA Repair Deficiency in Lung Tumor
- Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
- Disrupting Brain Metastogenesis in Breast Cancer
- Dissecting the genetics of follicular lymphoma to find new therapies
- Dissecting the role of stat3 and targeting ovarian cancer
- Dissecting the roles of TSC1 and TSC2 at the centrosome
- Distribution, regulation and function of a novel lysine ptm in metabolic disease
- DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations
- Drosophila models of Ret fusions in Papillary Thyroid Carcinoma
- Dual targeted nanoparticle therapy for glioblastoma multiforme
- Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics Data
- Early detection of pancreatic cancer in diabetics
- Ecog-acrin integrated leukemia translational research center
- Effects of uv irradiation on dna structure-induced genetic instability
- Elucidate the role of miR-141 in brain metastasis from breast cancer
- Elucidating and targeting epigenetic oncogenic networks in pancreatic cancer
- Elucidating the role and regulation of epithelial plasticity in metastasis
- Embryonal Brain Tumor Networks
- Enable early and sensitive in vivo detection of liver metastasis by protein-based
- Endothelial cell activation regulates aml growth and relapse
- Engineering a supramolecular platinum nanoparticle for pediatric cancer
- Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
- Engineering organelle function to rewire cancer cell metabolism
- Enhancing Glioma-Specific Immunity
- Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
- Enhancing oncolytic virus function with type iii interferon
- Epigenetic modulation of lung cancer metastasis by a novel long intergenic RNA
- Epigenetic priming in pancreatic cancer chemotherapy
- Epigenetic regulation of pancreatic cancer
- Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemia
- Epigenetics and Risk Factors for Breast and Ovarian Cancer in High Risk Women
- Epo increases macrophage suppression
- ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
- Establish RPN 13-Proteasome Association as a Novel Anticancer Target
- Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer
- Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
- EVALUATION OF POSITRON EMISSION TOMOGRAPHY-MAGNETIC RESONANCE IMAGING (PET-MRI)
- Ex vivo purging strategy for treatment of multiple myeloma
- Exercise and quality diet after leukemia
- Exosomal MicroRNA as a Driver of Immune Evasion in AML
- Exploiting Metabloic Defects in Tumors with Mutant IDH1 and IDH2
- Exploring a new therapeutic approach through targeting epigenetic enzymes in all
- Exploring the role of Mediator in oncogenic transcription
- Expression system and process development for mis scale up
- F10: a novel therapeutic to treat refractory or relapsed aml
- Failed tubulin inhibitor reformulated as localized adjuvant therapy for head and neck cancerpop: 09/12/2014-06/11/2015
- Fatty acid transporters in cholangiocarcinoma pathogenesis
- Fiber scanning stimulated raman scattering (srs) endoscope
- Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
- Fluorescence lifetime imaging/spectroscopy system for robotic cancer surgery guid
- Fluorescence lifetime technique for detection of radiation necrosis vs gliom
- FoxM1 in liver cancer.
- Frostbite – a unique catheter for endoscopic cryoablation
- Fullerene-based radioprotectors for use during brain radiotherapy, period of performance 09/15/2014 – 05/15/2015
- Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
- Function on Non-Coding RNA, MALAT1, in B-cell development and Lymphoma
- Functional analysis of BRCA1 in DNA damage response and tumor suppression
- Functional Analysis of LncRNAs in Epithelial Ovarian Cancer
- Functional and biologic significance of deacetylase3 inhibition in myeloma
- Functional Significance of CD133 in Pancreatic Cancer
- Functional significance of pre-leukemic hsc in human acute myeloid leukemia
- Genetic Dissection of Acute Myeloid Leukemia.
- Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
- Genetic Testing For Men From Hereditary Cancer Families
- Genomic Instability from Loss of XPG, a BRCA1/2 Partner: Role in Ovarian Cancer?
- Genomic instability mediated via differential DNA repair mechanisms in B cells
- Genomic profiling and development of murine models of transformation of MPNs
- Germline Susceptibility in Double Primary Cancers via Nexy-Generation Sequencing
- Global Assessment of Myeloma Response to Chemotherapy
- Glycocalyx and ncor2-notch-mediated stemness in glioblastoma aggressiveness
- GPCR Signaling in SCCHN: Integration with EGFR
- GPCRs: novel targets in cancer-associated fibroblasts
- GSK3 inhibition as an adjuvant therapy for Burkitts lymphoma
- H3K9 Methylation and Pancreatic Cancer Chemoresistance
- Harnessing the Multipotency of Cancer Stem Cells for Differentiation Therapy
- HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
- Healthy Kids after Cancer: A Physical Activity and Nutrition Intervention
- Hedgehog Acyltransferase as a target in cancer
- Hereditary cancer predisposition syndromes and uveal melanoma
- Hhsn2612012000131/hhsn26100010base contract title: preclinical efficacy and intermediate endpoint biomarkers. Task order title: preclinical studies to evaluate the combination of metformin and as
- Hhsn2612012000151/hhsn2610006base contract title: preclinical efficacy and intermediate biomarkers. Task order title: modulation of mirna expression in blood or other biological fluids compared wi
- Hhsn2612012000201/hhsn26100006 title: preclinical in vitro and in vivo screening assays for cancer preventative reagent development, project: targeting cck2r for pancreatic cancer prevention
- High dose radiation therapy to direct immune responses to pancreatic cancer
- High Resolution Helicobacter SNP Typing to Identify Carcinogenic cagPAI Variants
- Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
- High-resolution analysis of chromatin regulation by the Max network
- Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer
- Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
- Identify OTX2-interacting proteins repressing differentiation in medulloblastoma
- Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer
- Identifying new drug targets to block K-Ras/Raf in pancreatic cancer.
- Identifying signaling and anti-apoptotic dependencies in acute myeloid leukemia
- Identifying STAT3 Co-dependencies in Cancer
- Igf maternal folic acid supplementation and leukemia risk in children: a pooling of prospective data in the international childhood cancer cohort consortium (i4c)
- Igf::ot::igf – ind enabling development of nanogmp: targeted
- Igf::ot::igf sbir phase i topic 331: biopsy guidance with coherent raman spectroscopy
- Imaginab
- Imaging Guided Surgery using Fluorescently Labeled Cetuximab
- Imaging IDH1 Mutations in Glioma and Other Malignancies
- Immune-based brain cancer diagnostic for rapid, accurate disease classification
- Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
- Impact of low IL-10 levels at birth and leukemia risk
- Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
- Impact of primary tumor development stage on prognosis and outcome in B-ALL
- Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots
- Improved Response Assessment in Anti-Angiogenic Treatment of Glioblastoma
- Improving CPT-11 Efficacy Using Structural and Chemical Biology
- Improving extent of glioblastoma resection by combining volumetric MRSI and 5-ALA
- Improving Self-management in Head and Neck Cancer
- In Vivo Study of of Chemokine Antagonists for Cancer
- Individualized Peptide Monitoring for Plasma Cell Dyscrasias by Proteomics
- Inflammation, autoimmunity and ovarian cancer
- Inflammatory basis of depression in ovarian cancer
- Influence of germ line genetic variation on myeloma progression and survival
- Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy
- Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
- Instructive cues in glioblastoma hierarchies
- Intact protien as a cancer fuel source
- Integrated Microfluidic Exosome Profiling for Early Detection of Cancer
- Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
- Integrated Translational Genoproteomics Center at Washington University
- Integrating mass cytometric and transcriptomic profiles of solid tumors
- Integration of glycolysis with the epithelial-mesenchymal transition
- Integrative Modeling of Gene Expression into GWAS of Glioma
- Integrin AVB3 Targeted Nanoparticles as a Novel Therapy of Bone Metastases
- Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers
- Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
- Intervention of Ras-ERK-activated cancers
- Intervention of ras-erk-activated cancers
- Intraoperative confocal microscopy for quantitative delineation of low-grade glio
- Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer
- Intravenous Administration of Vesicular Stomatitis Vectors
- Investigating and Targeting TAMs in the Glioma Microenvironment
- Investigating Branched Chain Amino Acid Metabolism in Pancreatic Cancer
- Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis
- Investigating Resistance to FLT3 Inhibitors in AML
- Investigating the association between the somatic and inherited genetics of pheoc
- Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
- Investigating the function of mtbp in lymphoma
- Investigating the roles of lncRNAs in cancer and development
- Investigating Wnt and Lgr5 signaling as regulators of lung cancer heterogeneity
- Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer
- Investigation of tumor suppressive miR-148a in IDH mutant gliomas
- Investigations of Cryab activity in gliomagenesis
- IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
- Iron addiction and the biology of ovarian cancer
- Itraconazole Analogues to Treat Medulloblastoma
- ITSC for Leukemia: Novel Molecular Strategies for NCTN: Individualized Therapie
- Kaposis Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
- Kir-favorable haploidentical transplantation in children
- KSHV alteration of cellular metabolism
- KSHV interactions with host inflammasome components
- Large scale synthesis and biodistribution of expansile nanoparticles
- Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
- Leukotriene-Induced Nestin Expression Promotes Medulloblastoma Tumorigenesis
- Long non-coding RNAs in pancreatic cancer
- Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral
- Lynch syndrome screening network (lssn) database
- MALT1 Targeted Therapy for B-Cell Lymphoma
- Manipulation of kinase signaling by the human oncovirus KSHV
- Maternal comorbidities, prescription drug use in pregnancy and childhood cancer
- Mdct quantification of hepatic tumor viability for assessment of cancer therapy
- Mechanism of Notch-induced leukemogenesis in lymphocytes
- Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer
- Mechanisms governing tumor differentiation and metastasis
- Mechanisms of PAK1 activation, signaling and tumor resistance
- Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
- Mechanisms of tumor suppression by epigenetic regulators in pancreatic cancer
- Mechanisms of twist1-induced sorafenib resistance in liver ca
- Menin-mediated epigenetic tumor suppression
- Merkel cell polyomavirus T antigens and cancer
- Metabolic regulation of cellular junction proteins
- Metabolic reprogramming in liver cancer cells by a novel tumor suppressor
- Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate
- Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
- Micellar daunorubicin for the treatment of bone cancer
- Microfluidic approach for the development of a three-dimensional bone marrow micr
- Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures
- MicroRNA-125b physiologically and pathologically regulates myelopoiesis through I
- MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
- MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation
- Micro-western array methodology for assessment of preanalytical variability in bi
- Mode of action of the amaryllidaceae alkaloid lycorine-promising anticancer agent
- Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs
- Modeling p53 mutant-associated cancer with lfs patient-derived ipscs
- Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia
- Molecular analysis of physical microenvironmental control of tumor cell invasion
- Molecular and cellular communications in liver tumorigenesis
- Molecular basis for the impact of sex on brain tumorigenesis
- Molecular characterization of myeloma and related asymptomatic precursor states
- Molecular determinants of prognosis in limited-stage follicular lymphoma
- Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
- Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
- Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
- Molecular Genetics of Liver Cancers
- Molecular Insights into the Fanconi Anemia Tumor Suppressor Signaling Pathway
- Molecular mechanism of bitter melon juice efficacy against pancreatic cancer
- Molecular mechanism of oncogenic programming by histone demethylase GASC1
- Molecular Mechanism of Osteoblastic Inhibition in Myeloid Malignancies
- Molecular targets of translocation t(4;14) in multiple myeloma pathogenesis
- Molecularly Targeted Therapy for Lymphoma
- Monobody therapy for gynecologic cancers
- MR Guided Focused Ultrasound Controlled Stem Cell Therapy for Brain Tumor
- MRI fluorescence tomography for quantifying tumor receptor concentration in vivo
- MTDH regulates Fanconi anemia repair pathway to mediate drug resistance
- Mucins in the diagnosis and prognosis of pancreatic diseases
- Multi-Center Thyroid Tumor and Cancer Registry
- Multifunctional nanoparticles for combinational therapy of pancreatic cancer
- Multiplexed in vivo drug screening: Inhibitors of metastatic seeding
- Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp
- Multiplexed ovarian cancer microfluidic tissue microarray
- Multi-Tracer PET/CT Imaging of Gemcitabine Response in Pancreatic Cancer
- Nano-particles eradicating leukemia stem cells
- Natural History of Barretts Esophagus Using Capsule Endomicroscopy
- NCI NCTN- Network Lead Academic Participating Site: USC
- NCTN Deep South Research Consortium
- Needle biopsy preservation and preparation for rapid 3D pathology of pancreas
- Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
- Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors
- New Aminothiol Prevention of X-Ray-Induced Mouse Mutagenesis and Tumorigenesis
- New Cancer Therapeutic Target
- Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis
- Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin
- No-nonsense approach to treat myeloid malignancies with ASXL1 nonsense mutations
- Non-peptide proteasome inhibitors as a novel anticancer agent
- Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer Surgery
- Novel Allosteric Kinase Inhibitors Target Imatinib-Resistant GIST
- Novel and selective ampk activator for the treatment of hepatocellular carcinoma
- Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions
- Novel Cell Delivery Method for Brain Tumor Therapy
- Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
- Novel ERbeta agonists for the treatment of gliomas
- Novel Experimental Therapeutics for Pancreatic Cancer
- Novel focal adhesion kinase autophosphorylation inhibitors against pancreatic cancer
- Novel functions of Pyruvate kinase M2 in DNA double-strand break repair
- Novel immunotherapy for brain cancer
- Novel mechanisms of oncogenic transformation in lung cancer
- Novel role for shed syndecan 1 in promoting an aggressive tumor phenotype
- Novel role of SAMHD1 as a tumor suppressor in cutaneous T-cell lymphomas
- Novel scfv-antibody fusion sirna carrier protein for macroglobulinemia treatment
- Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy
- Novel small molecule therapeutics for pancreatic cancer
- Novel Theranostics for Pancreatic Cancer
- Novel therapeutic strategies targeting conformational plasticity of type I MAGE
- Novel topical radioprotector for gl mucosal exposure
- Nrg oncology network group operations center
- Nucleoside transporter-connexin interplay in pancreatic cancer chemotherapy
- OCT to Distinguish b/t Tumor & Non-Tumor Tissue in Infiltrating Brain Cancer
- Optimization of bifunctional pharmacophores for the treatment of neuroblastoma.
- Optimizing cancer photodynamic therapy using photoacoustic lifetime imaging
- Optimizing Radiosensitization in Anaplastic Thyroid Cancer with Metabolic Imaging
- Oral microbiome in esophageal adenocarcinoma
- Organ Preservation in Rectal Adenocarcinoma
- OSU as Network Lead Academic Participating Site for the NCI NCTN
- Ovarian cancer gene therapy using HPV pseudovirion
- Ovarian cancer therapy using cd40 ligand (cd40l)
- Ovarian cancer using novel nanoparticle formulations
- p130 and Pim-1 as prognostic biomarkers and therapeutic targets in lung cancer
- p90RSK2-Stathmin Signaling in Metastatic Human Cancers
- Pancreatic Cancer Cell Mechanics and Imaging
- Pancreatic cancer control by a novel combination treatment
- Pancreatic Cancer Vulnerabilities Downstream of Cooperating Oncogenic Mutations
- Pancreatic cystic lesions: descriptive epidemiology and natural history
- Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy
- Pancreatic-cancer imageable patient-derived orthotopic xenografts (ipdox)
- Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL
- Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinoma
- Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
- Pathogenic Mechanisms of CSF3R Mutations in Leukemia
- Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
- Patterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015
- Patterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015line item #: 1
- Patterns of care/quality of care study: diagnosis year 2013 seer) hhsn261201300017i – university of utah; pop 08/15/2014 – 08/14/2015 to# hhsn261200004
- Patterns of care/quality of care study: diagnosis year 2013seer) hhsn261201300015i – emory university pop 08/15/2014 -08/14/2015, to# hhns261200005
- Patterns of care/quality of care: diagnosis year 2013 (seer)pop 08/15/2014 – 08/14/2015line item#: 1
- PD2/Paf1 and pancreatic cancer stem cells
- Peptide reporters for estimation of bcr-abl kinase activity in all patient cells
- Peptide-mediated delivery of siRNA for treatment of ovarian cancer
- Perinatal hormonal biomarkers and risk of testicular germ cell tumors
- Perinatal immune development and risk of childhood acute lymphoblastic leukemia
- Perioperative Stromal Depletion Strategies in Pancreatic Ductal Adenocarcinoma
- Persistent SIX2 expression as a first hit mechanism in Wilms tumorigenesis
- PET Imaging-guided Personalized Therapy in Pancreatic Cancer
- PET/MR study of Metastatic Lymph Nodes in Head and Neck Cancer
- Phase I Vaccine Study using Brain Tumor Initiating Cells in WHO Grade II Gliomas
- Phenotypic plasticity associated with inhibition of hsp90
- Phosphoinositol-3-Kinase Signaling and PIK3CA: Critical Mitogenic Drivers in Head
- Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
- PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia
- Plasma and serum biomarkers for Hodgkin lymphoma
- Pluripotent stem cells as a novel model to test hereditary cancer variants
- Posterior cerebellar resection and pain processing in the pediatric brain
- Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
- PQD2 Rational Combination of Standard Agents and Immunotherapy to Treat Myeloma
- Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer
- Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer
- Predicting hcc through glycomics
- Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML
- Predictive MRI metrics for tumor aggressiveness in micropapillary thyroid cancer
- Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML
- Prevention of bone loss after pediatric hematopoietic cell transplantation
- Professional development and late career transitions in pediatric hematology/onco
- Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging
- Prognostic potential of low-level mutations in meylodysplastic syndrome
- Prohibitin 1 in liver injury and cancer
- Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
- Protein-coding and non-coding RNA biomarkers for early detection of CLL
- Puerto Rico NCI Community Oncology Research Program Minority/Underserved
- Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response
- Quantitative Analysis of GBM Invasion Mechanisms with New Imaging Protocol
- Quantitative MRI models of HN Cancers for Physiological Adaption of RT
- Quantitative MRSI for the prediction of response to chemoradiation therapy in GBM
- Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma
- Radiolabeled Trastuzumab to Improve Diagnosis and Staging of HER2+ Gastric Cancer
- Reactivation of p53 and apoptosis in patient derived aml cells with cytoplasmic s
- Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
- Refining ovarian cancer subtype classifiers to incorporate biologic features
- Regulation of cell migration by septin 2 in renal cancer
- Regulation of Lung Cancer Metastasis by ZEB1
- Regulation of redd1 and caspase-2 by fasn inhibition in ovarian cancer
- Regulation of transcription and tumor suppression by MTG family members
- Replicating tumor ecm in microchannels for 3d phenotypic hts assays
- REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
- Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
- Risk of hematologic cancers from repeated low-dose diagnostic radiation
- Role of acetyl-CoA in linking cancer cell metabolism and epigenetics
- Role of Age in Liver Cancer
- Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
- Role of autophagy in normal and transformed hematopoietic stem cells
- Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma
- Role of epigenetic regulators in pancreatic cancer
- Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
- Role of FOG2/GATA3 complex in lung cancer metastasis
- Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
- Role of inflammation in cancer progression
- Role of MEF2B mutations in lymphomagenesis
- Role of microRNAs in the regulation of CML stem cell self renewal and survival
- Role of MLL1 and MLL1 leukemogenic fusions in maintaining transcriptional memory
- Role of multiple myeloma cancer stem cells in clinical disease
- Role of p21 activated kinase in Leukemogenesis
- Role of Piceatannol in Cancer Cachexia
- Role of tumor-associated endothelial cells in chaperoning tumor cells
- Sbir phase ii topic “scalable automated brain tumor segmentationâ€
- Screening for inhibitors of the CBX chromodomain
- Second generation mti-101 analogs using a novel peptoid-peptide hybrid beta-hairp
- Selective transduction of radioprotector protein, Tousled, for treatment of cance
- Sensitize leukemia cells to differentiation by inhibiting necroptosis signal
- Sequence-based pathogen discovery in post-stem cell transplantation syndromes
- Shanghai Womens Health Study
- SHCC MU NCORP
- Signal Integration of Transcriptional Pathways in Gliomagenesis
- Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
- Sirt2 Directs Kras IR Cell Resistance and Tumorigenesis
- Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
- Smart targeting nano-doxorubicin against breast cancer
- Smo inhibitor resistance in shh-subtype medulloblastoma: mechanisms and treatment
- Sox9 signaling in lung adenocarcinoma
- Specificity of the Ubiquitin System in Lymphoid Malignancies
- Specificity of the ubiquitin system in lymphoid malignancies
- Stanford University NCTN- Network Lead Academic Site
- Stellate cells and their progenitor precursors in pancreas cancer progression
- Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
- Stem Cell Phenotype, GLUT3 expression, and Metabolic Stress Resistance in Gliobla
- Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
- Sting-activating gm-csf secreting allogeneic pancreas tumor cell vaccine therapy
- Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
- Stress response networks in cancer: systematic mapping and therapeutic potential
- Stroma-mediated clonal evolution in Multiple Myeloma
- Structure/Function of AF9 and MLL-AF9
- Studying metabolic stress signaling in renal cancer
- Sturge-Weber syndrome: Leveraging a Gene Discovery for the Future
- Survival Mechanisms in Leukemic NK Cells
- Synergy between mag-1 and cyclophosphamide for treatment of recurrent sclc
- Synthesis and evaluation of novel kinase inhibitors as anti-metastasis agents for
- Targeted chemoprevention of gastric carcinogenesis in high risk populations
- Targeted delivery of theranostic nanoparticles carrying immune modulators
- Targeted erythrocyte membrane-coated nanoparticles for the treatment of aml
- Targeted Therapies in CNS Lymphomas
- Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
- Targeting aerobic glycolysis in T-ALL
- Targeting BET Bromodomain in Pancreatic Cancer
- Targeting cancer stem cell initiation during pancreatic cancer development
- Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
- TARGETING CCR2 TO OVERCOME IMMUNOSUPPRESSION AND IMPROVE IMMUNOTHERAPY
- Targeting Cell Surface GRP78 as a Novel Therapy for Pancreatic Cancer
- Targeting Chromatin Modifications in Leukemia with Trisomy 21
- Targeting Chronic Lymphocytic Leukemia with DNA Nanoparticles
- Targeting DCLK1 kinase activity in pancreatic cancer
- Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms
- Targeting diacylglycerol kinases in glioblastoma
- Targeting DNA repair to eradicate TKI-refractory/resistant CML
- Targeting epigenetic regulation to disrupt glioma stem cell maintenance.
- Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma
- Targeting Gain-of-Function p53 Missense Mutants
- Targeting glioma stem cells by perturbation of telomere maintenance mechanisms
- Targeting lymphoma with modular anti-idiotype peptibodies
- Targeting metabolism in leukemic stem cells
- Targeting Mucin and EGFR Axis in Pancreatic Cancer
- Targeting NEDD8-Mediated Protein Turnover in AML
- Targeting Neuroblastoma with armed T cells
- Targeting N-linked Glycosylation to Enhance Radiation Therapy
- Targeting Ovarian Cancer via Cooperative Oncogene Interactions
- Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
- Targeting SIRT1 in Mantle Cell Lymphoma
- TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA
- Targeting Stat1 and Stat3 to Reverse Radioresistance in Head and Neck Cancer
- Targeting Stem-Cell Dependent Drug Resistance in Human MCL
- Targeting TF/CD44v6 for In Vivo Nano-generated alpha-therapy of Ovarian Cancer
- Targeting the chondrosarcoma extracellular matrix for drug delivery
- Targeting the c-Met/HGF Axis in Acute Myeloid Leukemia
- Targeting the core binding factor tumor suppressor in mll-fusion aml
- Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
- Targeting the tumor microenvironment in B-cell malignancies
- Targeting tumor-microenvironment interaction to overcome leukemia chemoresistance
- Targeting tumor-stromal interaction for pancreatic cancer therapy
- Tethered Cationic Lipoplex Nanoparticle Assay for Liver Cancer Detection and Surv
- The addition of fish oil to sorafenib may prevent kidney cancer metastasis
- The biochemical contributions of ovulation to fallopian tube tumorigenesis
- The development of novel inhibitors of bcl2 gene expression as anticancer therape
- The feasibility of self or partner-assisted digital anal exam screening
- The genetics of SF1 (splicing factor 1) in cancers
- The mechanisms driving brain oncogenesis by FGFR-TACC gene fusions
- The molecular mechanism of isocitrate dehydrogenase (lDH) mutations in cancer
- The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
- The Regulation of Cisplatin resistance in ovarian cancer
- The role and functional mechanism of TET1 in MLL-rearranged leukemia
- The role of ampk signaling in the anti-leukemic effects of arsenic trioxide
- The role of ATRX and H3.3 mutations in pediatric glioblastoma
- The Role of Cereblon Pathways in Myeloma
- The role of CHD5 in chromatin-mediated regulation of neural stem cells and glioma
- The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
- The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
- The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
- The role of FAK in hepatocarcinogenesis
- THE ROLE OF LIN28B IN WILMS TUMOR
- The role of MDM2-MTBP axis in cancer metastasis
- The Role of NFAT3 in Quiescence and Chemoresistance in Ovarian Cancer Stem Cells
- The Role of Nup88 Overexpression in Cellular Transformation and Tumorigenesis
- The Role of Probiotic Bifidobacteria and Bile Acid Metabolism in Carcinogenesis
- The role of rb phosphorylation in proliferation and apoptosis of breast cancer ce
- The Role of SHIP-1 in the Modulation of Immunoregulatory Cells in Pancreatic Canc
- The Role of The Fanconi Anemia Pathway in Human Papillomavirus Infection
- The role of the protein tyrosine phosphatase PRL3 in leukemia development
- The role of viral and cellular miRNAs in B-cell lymphomagenesis
- The targeting of the HIF switch in kidney cancer
- The thrombospondin1-TGF-beta axis in multiple myeloma
- The tumor suppressive role of the mir-200 family of micrornas
- The use of epigenetic therapy to activate an immune response in ovarian cancer
- The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci
- Therapeutic antibody discovery from pancreatic cancer b cell repertoires
- Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
- Therapeutic In Situ Vaccination for Human Lymphoma
- Therapeutic targeting of the B-cell lymphoma associated mutation MYD88-L265P
- Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225
- Three-dimensional Model of Human Ewing Sarcoma
- Tools to Analyze Morphology and Spatially Mapped Molecular Data
- Towards The Chemotherapy-Free Treatment of Follicular Lymphoma
- Trail upregulation by tic10 analogs
- Transcription-dependent and -independent signaling of RSK2 in cancer metastasis
- Transition from Endometriosis to Ovarian Cancer: Role of Iron-Induced Autophagy
- Translesion DNA polymerase kappa activity in gliomas
- TREM-1 and Its Implications to Cancer
- Trial Participation Decision Making in Ovarian Cancer Patients and Their Families
- Trib1 in NF-kappaB Signaling: Insights into MALT1 Regulation and Leukemia
- Trisomy 8 in Hematopoiesis and Myeloid Leukemia
- Tsc1/mTOR axis in immune homeostasis and tumorigenesis
- Tumor Suppressor RASSF2 in t(8;21) Acute Myeloid Leukemia
- Tumor tight junction opener + chemotherapy conjugates to treat cancer
- Tumor-cell-specific targets for combined hyperthermia and radiation effects
- Two-Photon Fluorescence Lifetime Microscopy for Breast and Thyroid Cancer Margin
- Tyrosine kinase inhibition and immunomodulation for cancer
- Ubiquitin based therapy of aggressive cancer cell populations
- Uncovering the anti-apoptotic mechanism of mutated alk in neuroblastoma
- Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL
- Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods
- Unusual evolutionary patterns in brca1 and their implications for cancer
- Upregulation of nanog as an innovative mechanism for cancer drug resistance.
- Use of DND1 to counteract miRNA function in cancers
- Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
- Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
- Utility of Effusion Cytology and Image Analysis in the Diagnosis of Mesothelioma
- Utilizing HuR to optimize the treatment of pancreatic cancer
- UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
- Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
- Validating the prognostic value of EGFR768 in neuroblastoma
- Validation of a novel treatment for glioblastoma
- Validation of findings from the Epigenome-Wide Association Study of Breast Cancer
- Varicella virus antigens in glioma etiology and survival
- Virus discovery and characterization in large-scale cancer sequencing data
- Vlr-cart cancer immunotherapy
- Zileuton as a chemopreventive agent for chronic myeloid leukemia
- Zinc Chemoprevention of Arsenic Co-Carcinogenesis
- ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
2013
- (PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention
- (PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip
- (PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
- (PQC5) Detecting small clusters of tumor cells with a PTPmu probe
- (PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
- (PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition
- (PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
- (PQD6) Muscle stem cells and cancer cachexia
- A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia (website)
- A Novel Brachytherapy Agent for GBM (website)
- A novel NKG2D-specific BiTE cancer immunotherapy
- A novel photopatterning-based paradigm for the study of 3D tumor infiltration (website)
- A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer
- A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer (website)
- A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
- A Structure/Function Analysis of CTC1 Using Coats plus/DKC Mutations (website)
- A Surviorship Planning Tool for Head and Neck Cancer Patients and Caregivers (website)
- Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging (website)
- Activation and Signaling Mechanism of the RET Tyrosine Kinase Receptor
- Activity-Based Kinase Discovery In Small Cell Lung Cancer (website)
- Acute Myeloid Leukemia: MRD Analysis Using Modular uFluidics and uFlow Cytometry
- Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
- Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
- Advanced Glycation End-Products and Risk of Pancreatic Cancer
- Aging-associated alterations in adaptive landscapes and the evolution of leukemia
- Alpha Radioimmunotherapy for Lymphoma Treatment (website)
- Alternative Cleavage and Polyadenylation Events as Biomarkers (website)
- An integrated computational and functional genomics discovery engine for preclini
- An osteolytic stimuli-responsive nanotherapeutic system for bone metastases
- Analysis of Initiating Events in Inv(16) Associated Acute Myeloid Leukemia
- Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
- Analysis of the role of the SWI/SNF complex in tumor suppression
- Angiocidin, a Novel Differentiation Agent for the Treatment of Leukemia (website)
- Anit-PR1 Immune Therapy for Myeloid Leukemia (website)
- Annexin A2 as a mediator of pancreatic cancer metastases
- Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing (website)
- Antagonizing oncogenic microRNAs for the elucidation and treatment of lymphoma (website)
- Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase (website)
- Apoptosome Regulation in Leukemia by Protein Phosphatase 5 Hypoacetylation (website)
- Asymmetric Synthesis of Exiguaquinol and Analogs for Biological Testing
- Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis (website)
- Axl as a target for the therapy of pancreatic cancer (website)
- B7H1 Mediated Immunosuppression in Glioma (website)
- B7-H1 mediated immunosuppression in immunocompetent animal model of gliomas (website)
- Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty
- BET bromodomain inhibition as targeted therapy in acute myeloid leukemia (website)
- Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia (website)
- Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans (website)
- Biomaterials for treatment of head and neck cancer (website)
- Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
- Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
- Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation
- Brain Tumor Sport Grant
- Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
- BRCA1 and BRCA2 missense mutations and breast cancer risk
- Carbonyls to Cancer Therapeutics (website)
- CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER
- Cell Fate Control by Integrated E2F, FoxO and PI3K Signaling in Retinoblastoma
- Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia (website)
- Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection
- Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma
- Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia (website)
- CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML
- Chemical Genetic Dissection of Aurora A in Promoting EMT and Stem Cells Phenotype (website)
- Chemoprevention by black raspberry in oral cancer induced by DB[a,l]P in mice
- Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor (website)
- Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer
- Chromatin Regulation of KSHV Primary Infection
- Circulating tumor cells in hepatocellular carcinoma (website)
- Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas (website)
- Classifying DNA Mismatch Repair Gene Variants of Unknown Significance (website)
- Comb External Beam Radiotherapy with 153Sm-EDTMP to Treat High Risk Osteosarcoma (website)
- Combination therapies with interleukin-21 in chronic lymphocytic leukemia (website)
- Companion Diagnostic for Multiple Myeloma (website)
- Crenolanib and ponatinib for the treatment of FLT3 mutant AML (website)
- Deciphering the Role of eIF5A/PEAK1 Pathway in Pancreatic Cancer
- Decision Models to Compare Treatments in Older Patients with AML (website)
- Defining a Molecularly Distinct Subtype of Non Small Cell Lung Cancer (website)
- Defining mechanisms of extracellular communication for cancer therapy (website)
- Defining the impact of clonal evolution on chronic lymphocytic leukemia
- Deregulated microRNAs in Acute Myeloid Leukemia (website)
- Determination of the role of CHD5 tumor suppressor in the zebrafish model
- Determining the Roles of ATRX and DAXX Abnormalities in Cancer Telomere Biology (website)
- Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers (website)
- Development of GZ38-1, a Novel Protectant of Chemotherapy-Induced Myelosuppressio
- Development of New Therapeutics for Pancreatic Cancer Management (website)
- Development of TAK1 Inhibitors to Treat Pancreatic Cancer (website)
- Development of Therapeutic CD59 inhibitor for treating B-cell malignancies (website)
- Diagnostic Utility of Culdocentesis in Patients with a Suspicious Adnexal Mass
- Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
- Dietary Selenium, Selenoenzyme Genes and Adult Glioma (website)
- Differentiation Therapy of Uveal Melanoma Micrometastases
- Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site (website)
- Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer (website)
- Discovery of chemical probes for uveal melanoma
- Dopamine as a therapeutic agent in stomach cancer (website)
- Effect of anti-S phase agents on human chromosomes (website)
- Effects of common polymorphisms in immune sensors in tumor immunosurveillance
- EGFR Activation in H. Pylori-Induced Gastric Cancer (website)
- Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors (website)
- Elucidating the Role of MiR-31 in Retinoblastoma Invasion (website)
- Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector
- Enhancing dendritic cell migration to drive potent anti-tumor immune responses
- ENHANCING ONCOLYTIC VIROTHERAPY WITH TYPE III INTERFERON
- Enhancing Translational Science via Prospective Investigation
- Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma (website)
- Epidemiologic factors and survival by molecular subtypes of ovarian cancer
- Epigenetic alterations in oral rinse as biomarkers of oral and pharyngeal cancer
- Epigenetic Modulation of GvHD and GvL
- Epigenetic profiling of hepatoblastoma tumors with respect to low birth weight (website)
- Epigenetics and Epigenetic Therapy in AML (website)
- Epigenomic determinants of clinical outcomes in MCL patients treated on E1405 (website)
- Esophageal Cancer from Cells to Population: A Multiscale Approach (website)
- Estrogen Receptor Targeted Treatment Of Non-Muscle Invasive Bladder Cancer (website)
- Evaluation of HCC Response to Systemic Therapy with Quantitative MRI (website)
- Evaluation of MSP Antagonists for the Treatment of Pancreatic Cancer (website)
- Evaluation of Patient-Matched Primary and Metastatic Samples to Identify and Vali (website)
- Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
- Ewing’s Sarcoma Resistance to Immunity and Radiation (website)
- Exploiting tumor stroma interactions for cancer therapy (website)
- Exploration of a Mutant p53 Reactivating Compound
- Exploring Sarcoma Metastatic Potential (website)
- Feature Selection for Genomic Data Using Known and Novel Biological Information
- Flt3L Treatment of Pancreatic Cancer (website)
- Fluorescence Image-Guided Near Infrared (NIR) Photodynamic Therapy (PDT) Agent
- Functional Evaluation of Human Pancreatic Cancer Genes in a Zebrafish System (website)
- Functional Evaluation of microRNAs in Pancreatic Neoplasia (website)
- Gastric Histopathology Core
- Gene Methylation Signatures for Predictive Classification of Response to Therapy (website)
- Generation of humanized mouse model of medulloblastoma (website)
- Genetic and pharmacological manipulation of system xc in pancreatic cancer
- Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas
- Genetic network analysis of cancer targets (website)
- Genetic Risk Prediction in Primary Care (website)
- Genetic Susceptibility and Risk Model for Pancreatic Cancer
- Genetic Susceptibility and Risk Model for Pancreatic Cancer (website)
- Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas (website)
- Genetics pathways in intra-hepatic cholangiocarcinoma
- Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma (website)
- Genome maintenance functions of CREB/ATF transcription factors
- Genome-wide Case-control Association Study of Pancreatic Cancer in Jews (website)
- Genotype and phenotype of chemoresistant AML (website)
- Germline KLLN Alterations in PTEN Mutation Negative Cowden Syndrome (website)
- Glioma immunotherapy with strategies based on autonomous parvovirus MVMp (website)
- Grp94 targeted therapy for pancreatic ductal adenocarcinoma (website)
- HBV replication and carcinogenesis
- HDAC3 – a therapeutic target in PDA (website)
- Head and Neck squamous cell carcinoma radiation response modulation by HPV
- Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer (website)
- Helicobacter pylori blood biomarker for gastric cancer risk in East Asia
- Helicobacter pylori cag Pathogenicity Island and Gastric Carcinogenesis (website)
- HIF-2alpha mediated mitophagy and lipogenesis in clear cell renal cell carcinoma (website)
- High quality CTC isolation using microbubbles for downstream molecular analysis
- High Throughput Screening (HTS) to Discover Graft-Versus-Host Disease Inhibitors (website)
- HISTONE H3 METHYLATION AND EPIGENOMICS IN ACUTE LEUKEMIA
- HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma (website)
- HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
- Human cytomegalovirus in the promotion of glioblastoma multiforme pathogenesis (website)
- Human Endogenous Retroviral Sequences, a Tool to Study the Role of Centromeres in
- Hypersensitivity of Multiple Myeloma Bone Disease to Vitamin D (website)
- Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy (website)
- Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
- Identification and modeling of driver genetic modules in glioblastoma
- Identification of KSHV miRNA targets in endothelial cells and characterization mi (website)
- Identification of Melanoma Brain Metastasis Tumor Biomarkers (website)
- Identifying c-Cbl as a critical point of intervention in glioblastoma multiforme
- Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML (website)
- Identifying non-coding RNAs for early detection and prevention of lung cancer
- Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
- Identifying Regulators of Oncogenic CARD11 in Diffuse Large B Cell Lymphoma (website)
- IDO-silencing Salmonella therapy for the treatment of primary and metastatic PDAC (website)
- IGF1R gene 3′UTR variants in high-risk pediatric neuroblastoma
- Imaging Guided Genomics of Malignant Transformation (website)
- Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients
- Impact of B-Cell Lineage on Progression of B-Acute Lymphoblastic Leukemia (website)
- Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients (website)
- Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR (website)
- Improving Pancreas RT Plans using Respiration-driven Anatomic Deformation (website)
- In vivo imaging of encapsulated stem cells in mouse models of tumor resection (website)
- In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer (website)
- Incorporating FLT3 Inhibitors into Acute Myeloid Leukemia(AML)Treatment Regimens (website)
- Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas (website)
- Inflammatory processes In diet-Induced pancreatic cancer promotion (website)
- Inhibiting VHL-positive kidney cancer (website)
- Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction
- Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEH
- Inhibitors of IgH Gene Enhancers for the Treatment of Multiple Myeloma (website)
- Inhibitory targeting of HHV-8 vIL-6-related interactions (website)
- Innovative approach to cancer detection and treatment monitoring (website)
- Integrated high-throughput screen to identify treatment leads for pediatric AML
- Interleukin-8 Regulation by Proteasome and Nuclear IkB in Cancer and Inflammation (website)
- Interplay between intrinsic and extrinsic force and glioma aggression (website)
- Intraoperative imaging of breast cancer margins using Polarization Subtraction Te (website)
- Invasion of glioblastoma multiforme (GBM) cells in organotypic brain slices (website)
- Investigating MicroRNAs and Their Regulatory Networks in Glioblastoma (website)
- Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
- Investigating the tumor suppressive functions of the miR-34 family of microRNAs
- Investigating YAP’s role during pathogenesis of pancreatic ductal adenocarcinoma
- Investigation of a novel regulator of Myc-driven tumorigenesis (website)
- KSHV Abortive Replication Following De Novo Infection (website)
- KSHV genome modification in KS tissue (website)
- KSHV microRNAs in cellular transformation and tumorigenesis
- KSHV Persistence and Pathogenesis (website)
- Lig4R278H contribution to HSC and IgH class switching defects and malignancies
- LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel (website)
- LuIII parvovirus targets glioma (website)
- Lung Adenocarcinoma Invasion Genomics
- Lymphocyte trafficking blockade in allogeneic stem-cell transplantation
- MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL (website)
- Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
- Mechanism of action of Prdm16 in hematopoietic stem cells (website)
- Mechanism-based therapies for pancreatic cancer informed by stromal microrheology
- Mechanisms and Function of Autophagy in Cancer (website)
- Mechanisms and modifiers of beta-catenin-induced hepatic tumorigenesis
- Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
- Mechanisms of acquired temozolomide resistance in glioblastoma multiforme (website)
- Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
- Mechanisms of action of the Smyd3 methyltransferase in cancer cells (website)
- Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion (website)
- Mechanisms Promoting Angiogenesis in Glioblastoma (website)
- Mechanistic Dissection of the Fanconi Anemia Pathway of DNA Damage Response and R (website)
- Mechanistic Insights into TET-Mediated Demethylation in Leukemia
- Meso-plex miRNA and protein profiling for cancer diagnostics using chip-integrate
- Metabolic Adaptive Responses in Cancer
- Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss
- Metabolic Reprogramming in Brain Tumors (website)
- Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy (website)
- Microbiomes in Human Pancreatic Cancer (website)
- Microenvironmental impact on HNSCC response to targeted therapy (website)
- Microenvironmental Regulation of Leukemia Stem Cells
- Microenvironment-Leukemia Communication Through Lectins (website)
- Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme
- Microvesicles and exosomes as a cancer biomarker detected with designed peptides
- Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling (website)
- MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma (website)
- MKP-1 Effects on HIF-1alpha and Glycolytic Metabolism in Glioblastoma multiforme
- Modeling and microsystems approach to glioma invasion
- Molecular Basis of Familial Paraganglioma
- Molecular Biology of Lung Cancer among Puerto Ricans (website)
- Molecular Dissection of Lung Cancer Progression and Metastasis
- Molecular Fluorescence-Guided Surgery Platform (website)
- Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4 (website)
- Molecular Mechanism of Hepatocyte Growth Factor Signaling
- Molecular Mechanisms of Prostate Cancer Induced Bone Remodeling (website)
- Molecular Mediators of Pancreatic Cancer Invasion and Progression (website)
- Molecular Target Variation Across Environments and at Margins of Glioblastoma (website)
- Motion Management Using 4D-MRI for Liver Cancer in Radiation Therapy (website)
- Mouse models of glioma to study functional exRNA transfer to the microenvironment (website)
- MR Image Guided Gynecologic Brachytherapy (website)
- MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients (website)
- MR-Guided Precision Conformal Ablation Therapy for Brain Tumors
- MR-Guided Precision Conformal Ablation Therapy for Brain Tumors (website)
- MUC1 enhances Neuropilin-1 signaling in pancreatic ductal adenocarcinoma (website)
- MUC1 regulation of TGF-beta function in pancreatic cancer cells (website)
- Mucus Penetrating Nanoparticles for Small Cell Lung Cancer (website)
- Multifunctional immunoPET tracers for pancreatic and prostate cancer (website)
- Multifunctional nanoparticles to improve treatment of human glioblastoma (website)
- Nanoparticle Enabled L-asparaginase Therapy for CLL (website)
- Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy (website)
- Natural Killer Cell Regulation by PRDM1 and IRF4/8
- N-cadherin and Metastatic Dissemination
- Negative feedback signaling in tyrosine kinase-driven leukemia
- New 3D tumor models to rapidly test drugs for brain cancer therapy
- New Models and Treatments for AIDS-related Lymphoma
- Next Generation Oncolytic Adenovirus for Advanced Pancreatic Cancer Treatment (website)
- NMDA receptors in the diagnosis and treatment of pancreatic cancer (website)
- Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin (website)
- Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer (website)
- Novel adhesion mechanisms in glioblastoma stem cells (website)
- Novel Anti-HER3 Strategy for Pancreatic Cancer (website)
- Novel Approacahes For Improving Pediatric Brafv600e Glioma Patient Outcomes (website)
- Novel Biomarkers Of Malignant Progression In Recurrent Low Grade Glioma (website)
- Novel Cell Cycle Therapeutic Targets in Pancreatic Cancer (website)
- Novel Chemotherapeutics for Brain Tumors (website)
- Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer
- Novel lysine deacetylase 6 Hsp domain inhibitors against AML (website)
- Novel monocyte effector function in CLL immune therapy
- Novel Nanoparticle Therapy for Pancreatic Cancer (website)
- Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression (website)
- Novel Targeted Therapy for AML (website)
- Novel treatment strategies for enhancing sunitinib response in renal cell cancer (website)
- Novel Vitamin B6 based prodrugs of gemcitabine (website)
- Optimization of adoptive immunotherapy with autologous CD20-specific T cells
- Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma (website)
- Optimizing selective in vivo inhibition of pancreatic tumor JAK2/STAT3 signaling (website)
- Oral Biomarkers for HPV-related Head and Neck Cancer (website)
- Osteosarcoma in Dogs as a Model for the Development of Drugs to Treat Micro-metas (website)
- Overcoming Inferior Quality of Vaccine Responses After Alkylating Chemotherapy (website)
- Overcoming Local And Peripheral Immune Suppression In Glioma To Facilitate Effec (website)
- Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma (website)
- Overcoming Temozolomide Resistance using MGMT-targeting Spherical Nucleic Acids (website)
- P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia (website)
- Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers (website)
- PARP Inhibition To Enhance Induction for Head and Neck Cancer (website)
- PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL
- PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer
- Peptide vaccine-based immunotherapy for children with recurrent ependymomas (website)
- Pharmacogenetics in children with high-risk neuroblastoma (website)
- Pharmacokinetics and pharmacogenomics for 13-cis retinoic acid in neuroblastoma
- PKA and follicular thyroid carcinogenesis: Roles of interacting pathways (website)
- Plasma Biomarkers of Acute Graft Versus Host Disease (website)
- Platelets promote growth of ovarian cancer
- Pneumatic Robot for MRI-Guided Pediatrics Long Bone Biopsy
- Polysomy 21 in Acute Lymphoblastic Leukemia (website)
- PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip (website)
- Predicting deficits in social competence for pediatric brain tumor survivors
- Predictive Epigenomic Biomarkers In Rectal Cancer Patients Receiving Treatment
- Profiling cancer neoantigen repertoires and validating immunotherapy targets
- Profiling Pancreatic Cancer Metabolism and Tumor Microenvironment for Therapy (website)
- Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport
- Quantify treatment response in IDH1 mutant glioma patients with metabolic MRI
- Quantitative Image Informatics for Cancer Research (QIICR)
- Quantitative MRSI to predict early response to SAHA therapy in new GBM management (website)
- Quantitative PET/CT Analysis to Improve Evaluation of Tumor Response
- Quantitative Spectroscopic Imaging of Cancer Metabolites in Live Cells and Intact
- Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease
- Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma (website)
- Radioactive Stents for Brachytherapy of Esophageal Cancers (website)
- RECEPTOR TARGETED MOLECULAR IMAGING OF MULTIPLE MYELOMA
- Recombinant Polymers for Transarterial Chemoembolization of Liver Cancer
- Reconstitution of Regulatory T Cells After Stem Cell Transplantation
- Regional Quantification of Lung Function in Cystic Fibrosis using Xe129 MRI (website)
- Regulation and function of Six1 in zebrafish muscle development and in rhabdomyos (website)
- Regulation of a DNA damage response network in glioblastoma
- Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
- Regulation of Hypoxia-inducible Factor 1 by Cyclin Dependent Kinases (website)
- Regulation of molecular thermal ablative resistance in hepatocellular carcinoma (website)
- Regulation of Tumor Metabolism by Retinoblastoma Protein (website)
- Restoring anti-tumor immunity in the microenvironment of head and neck cancer (website)
- Rhodium(II)-based inhibitors for STAT family oncoproteins
- RNA Splicing Modulators for MDS/AML (website)
- RNAi screen for chromatin regulators of differentiation in Acute Myeloid Leukemia (website)
- Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia (website)
- Role Of Aca11, An Orphan Small Nucleolar Rna In Resistance To Cancer Chemotherapy (website)
- Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development (website)
- Role of Id1 in adiposity, energy balance and obesity associated liver tumorigenes (website)
- Role of IDH Mutations in Acute Myeloid Malignancies
- Role of IRF-1 dependent chemokines in glioma
- Role of IRF4-NOTCH2 Interplay in B-Cell Development and Malignancy (website)
- Role of LANA-RBP-jk During Early KSHV Infection
- Role of microRNA-124 in counteracting glioblastoma adaptation to cellular stress (website)
- Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma (website)
- Role of Neurogenic Inflammation in Pancreatic Cancer (website)
- Role of NFxB/HIF2a axis in renal cell carcinoma progression (website)
- Role of noncoding RNA in Regulating GVHD
- Role of Obesity-Induced Immunosuppression in Pancreatic Cancer (website)
- Role of Shcbp1 (mPAL) in T Cell Development and Function
- Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia (website)
- Role of TET2 mutations in malignant transformation and acute myeloid leukemia (website)
- Roles of Chromatin Modification in BRCA1 Dependent DNA Repair
- Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation (website)
- Roles of MicroRNAs in KSHV Persistence and Pathogenesis (website)
- Roles of Nucleotide Metabolic Control in KSHV Persistence (website)
- Roles of PTPN11 in regulating and driving epithelial cancer
- Roles of the K3 and K5 in KSHV Persistence and Pathogenesis (website)
- RPCI-UPCI Ovarian Cancer SPORE
- Screening for modulators of glioma stem cells differentiation (website)
- Sensitizing Leukemia Stem Cells to NF-kB Inhibition by Blocking TNF Signaling (website)
- Sensor-assisted prevention of dehydration in head and neck cancer patients
- Single molecule microarrays for the detection of mutant DNA in body fluids
- Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
- Sleeping Beauty Mediated Therapy for Alpha V Beta 6-Expressing Pancreatic Cancer (website)
- SPARC as a regulator of collagen signaling in Pancreatic Cancer (website)
- Specialized Program Of Research Excellence (SPORE) in Leukemia
- SPORE: Targeted Therapies for Glioma (website)
- Studies of Childhood Sarcomas (website)
- Suppression of BCR-ABL by siRNA-loaded Nanoparticles for the Treatment of CML (website)
- Survival Bump Hunting for Finding Informative Subgroups in High Dimensional Data (website)
- Swallow Function and Oral Morbidities in RT Treated Head/Neck Cancer Survivors (website)
- Synergistic interactions between SapC-DOPS and chemotherapy for glioma (website)
- Synthesis of Vinblastine Analogues with Improved Physiochemical Properties (website)
- Systemic Nanocurcumin for Pancreatic Cancer Therapy (website)
- Targeted Docetaxel-Nanocolloid for the Treatment of Ovarian Cancer (website)
- Targeted Elimination of Cancer Stem Cells for AML Therapy (website)
- Targeted Sphing »omics »Core (website)
- Targeted Sphingolipid Metabolism for Treatment of AML (website)
- Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia (website)
- Targeted Therapy for AML Stem Cells (website)
- Targeted Therapy for Lymphoid Malignancies (website)
- Targeting Acid Ceramidase in AML (website)
- Targeting AML with PI3K/AKT inhibitors and BH3-mimetics (website)
- Targeting Antigen-Induced Er Stress Response In B-Cell Chronic Lymphocytic Leukem (website)
- Targeting B-cell lymphoma with Leukothera (website)
- Targeting Caregivers to Enhance Health Behaviors in Pediatric Cancer Survivors (website)
- Targeting Ceramide Glycosylation in AML (website)
- Targeting Ceramide Metabolism in AML (website)
- Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas (website)
- Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma (website)
- Targeting Deep Brain Tumors with MRI-Insertable Magnetic Gradients and Nanopartic (website)
- Targeting DEPTOR in multiple myeloma (website)
- Targeting Ferritin in Glioblastoma
- Targeting glioma stem cells by perturbation of telomere maintenance mechanisms (website)
- Targeting IL-12/23 p40 Pathways for the Control of GVHD (website)
- Targeting K-Ras effector signaling for pancreatic cancer treatment
- Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
- Targeting nucleotide excision repair in combination cancer therapy
- Targeting Pancreatic Cancer with Aptamers to the CCK-B Receptor (website)
- Targeting Radiation Resistance in Glioblastoma Stem Cells (website)
- Targeting RAGE in pancreatic cancer (website)
- Targeting RET in Lung Cancer
- Targeting Sphingosine Kinase in AML (website)
- Targeting Stromal Collagen in Pancreatic Cancer (website)
- Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia (website)
- Targeting the C/EBPalpha-Gfi-pathway in CML stem cells (website)
- Targeting the Chk1-Suppressed Apoptotic Pathway in HNSCC
- Targeting the IDH Pathway
- Targeting the MLL-WDR5 protein-protein interaction (website)
- Targeting the OLIG2 Transcription Factor
- Targeting the PI3K Signaling Axis
- Targeting the translational apparatus in MYCN-driven pediatric solid tumors (website)
- Targeting the Urokinase Receptor in Glioblastoma Multiforme (website)
- Targeting y-secretase in GVHD
- Temporal regulation of the essential Epstein-Barr virus oncoprotein LMP1
- The BARD1 tumor suppressor and breast cancer
- The contribution of rare alleles to ovarian cancer in the population
- The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
- The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
- The Function of EBV LMP1 CTAR3 in Sumoylation and Oncogenesis (website)
- The Genetics of Post-Transplant Relapse in Myeloid Malignancy
- The Hippo Signaling Pathway in Pancreatic Cancer (website)
- The Impact of Treatment Adherence on A Clinical Biomarker in Pediatric Acute Lymp (website)
- The Oncogenic Role of miR-9 in MLL-Associated Leukemias (website)
- The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis
- The role of b-catenin/Tcf-1 signaling in T-cell leukemia/lymphoma
- The role of ETV6 in T-cell acute lymphoblastic leukemia (website)
- The Role of FBXL4 in T-cell Acute Lymphoblastic Leukemia (website)
- The role of GATA-3 in T-cell lymphomas
- The Role of Growth Factor Receptor Trafficking in Tumorigenesis (website)
- The role of HO-1 in Flt3-ITD positive AML proliferation and drug resistance (website)
- The role of ICSBP in the pathogenesis of chronic myeloid leukemia (website)
- The Role of IKK and NF-kappaB in Controlling mTOR Signaling and TSC Progression
- The role of inhibitory receptors in leukemia development (website)
- The Role of JAB1 in osteosarcoma pathogenesis (website)
- The Role of miRNA Network in Gastric Cancer
- The Role of MMP13 in Multiple Myeloma Bone Disease
- The role of MTG8 in transcriptional elongation and leukemia (website)
- The Role of NOTCH1 in the Pathogenesis of CLL (website)
- The Role of p120ctn in Pancreatic Ductal Morphogenesis and Adenocarcinoma
- The Role of Post Traumatic Stress and Substance P in Melanoma Brain Metastasis (website)
- The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel
- The role of the stromal cell surface protease FAP in pancreatic cancer (website)
- The study of novel miRNA in lung cancer initiation and metastasis (website)
- The Tribbles-COP1 Complex in Leukemia (website)
- The Welfare Consequences of Oncology Drug Shortages (website)
- Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
- Therapeutic Targeting of Leukemia-Microenvironmental Interactions (website)
- TIC10 anti-tumor effect through regulation of Foxo3a and TRAIL
- TLR4 in obesity-driven liver cancer (website)
- Toll-like Receptor Regulation of Pancreatic Tumorigenesis (website)
- Training and Mentorship of Hematologic Oncologists
- Transcriptional Coregulation in Pancreatic Adenocarcinoma Progression (website)
- Transcriptional regulation of H. pylori-mediated gastric inflammation and cancer
- Transcriptional regulatory mechanisms in B cell development and leukemogenesis
- Transforming Mechanisms of Merkel Cell Polyoma Virus
- Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease (website)
- Translation of Novel Therapeutic Targets in Multiple Myeloma (website)
- Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity
- Tumor antigen-specific T-cells and hepatocellular carcinoma (website)
- Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
- TWEAK-Fn14 HTS compound screening
- TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
- TXNIP as a regulator of thyroid cancer aggressiveness (website)
- Understanding the epigenetic basis of human familial paraganglioma
- Understanding the role of altered metabolism in gliomagenesis (website)
- Unmetabolized folic acid and retinoblastoma (website)
- Urinary metalloproteinases and ovarian cancer risk in a prospective cohort (website)
- Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
- Using Markers to Improve Pancreatic Cancer Screening
- Validation and Development of WEE1 as a therapeutic target in AML
- Viral oncoprotein targeted immune therapy for Merkel cell carcinoma (website)
- Womens Health Initiative Cancer Survivor Cohort (website)
2012
- 5-hydroxymethylcytosine in human cancer (website)
- A Highly Multiplexed PCR Platform for Gene Expression Profiling from FFPE Tissue
- A Multi-Purpose Nanovehicle for Targeted Boron Neutron Capture Cancer Therapy & I (website)
- A novel diagnostic biomarker for hepatocellular carcinoma and cholangiocarcinoma (website)
- A novel model system for risk assessment of BRCA carriers (website)
- A Predictive Prognostic Model for Glioblastoma Multiforme (website)
- A Role for Fatty Acid Binding Protein 4 in Ovarian Cancer Metastasis (website)
- A Translational Model of Evolution of Myeloma Adhesion-Mediated Drug Resistance (website)
- ADAM17 in pancreatic cancer and pancreatitis (website)
- Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse (website)
- Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis (website)
- Alternative RNA splicing and protein products in leukemia outcome (PQ11) (website)
- An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9) (website)
- An Orthotopic Murine Model of HCC: Immunotolerance and Prevention (website)
- Animal model of Gardner’s syndrome, a life threatening form of familial cancer (website)
- Anticancer Drug Pharmacology in Very Young Children (website)
- Antiprogestin therapy for ovarian cancer (website)
- Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus (website)
- Ascorbate-Induced Radiosensitization In Pancreatic Cancer (website)
- ATP-Dependent Chromatin Remodeling in Human Malignancy (website)
- Automated Ultrasensitive Detection of Light Chain Restriction in Lymphoproliferat
- Axl receptor signaling in MPNST; potential node for therapy (website)
- Biological Variants Underlying Racial Differences in Lymphoma (website)
- Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound (website)
- Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Osteosarcoma (website)
- Cancer Cell Overexpression of Death Receptor Modulator (website)
- Cancer epigenetics: Understanding histone methylation in leukemia stem cells (website)
- Capsaicin and Small cell Lung Cancer Therapy (website)
- CD147 Biological Function and Role as a Biomarker of MGUS to Myeloma Progression (website)
- CD20-targeted IL-15 immunotherapeutic for B-cell malignancies (website)
- Cell invasion, motility, and proliferation level estimate maps in gliomas (website)
- Cell-specific analysis of transcription and epigenomic status in PDAC (website)
- Cellular plasticity and survival mechanisms in medulloblastoma stem cells (website)
- Characterization And Targeted Therapy Of T-All Deficient For Pten And Ink4a/Arf (website)
- Characterization of a T cell dysfunctional state induced in mice with AML (website)
- Characterization of ER-localized Activity of HHV-8 Interleukin-6 (website)
- Characterization of the LGL Leukemia Virus (PQ 12) (website)
- Chemoprevention of pancreatic cancer witli antidiabetic agents (website)
- Chronic Convection Enhanced Delivery (Ced) Of Topotecan For Glioblastoma (website)
- Combination immunotherapy for neuroblastoma: model of innate tumor immunity (website)
- Comparative Genomics Study of Foxa/ER Targets in Liver Cancer and Breast Cancer (website)
- Comprehensive Evaluation of OGSE DWI for Assessing Tumor Treatment Response (website)
- Construction And Testing Of A Trivalent Vaccine Against Neuroblastoma Administere (website)
- Convergence of CREB and MYC Pathways in Oncogenesis (website)
- Cotranslational Functions of MTOR (website)
- Cyclophosphamide modified GM-CSF pancreatic tumor vaccine + listeria-mesothelin (website)
- Cytochrome C Oxidase in Malignant Gliomas (website)
- Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis (website)
- Defining PI3K p110alpha as a therapeutic target in pancreatic cancer (website)
- Defining the role and regulation of the RhoGEF Ect2 in ovarian cancer cells (website)
- Design of MEK Inhibitor Regimens for the Treatment of Pancreatic Cancer (website)
- Development of a diagnostic biomarker for Ewing’s Sarcoma family of tumors (website)
- Development of a Urine Test for the Early Detection of Liver Cancer (website)
- Development of Novel Drugs to Alleviate CPT-11 Toxicity (website)
- Development of novel thiobarbituric acid analogs for malignant brain tumors (website)
- Development of Small Molecule Crm-1 Inhibitor for Pancreatic Cancer Therapy (website)
- Devices enabling improved light delivery for photodynamic therapy of oral cancer (website)
- Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt (website)
- Discovering genomic rearrangements under selection in serious ovarian cancer (website)
- Discovery and Targeting of Apoptosis Resistance Mechanisms in High-Risk T-ALL (website)
- Discovery Of Small Molecular Activators Of Nr4a Orphan Nuclear Receptors (website)
- Dissection and manipulation of RB function (website)
- DNA methylation markers for early detection of thyroid cancer (website)
- Do barriers to transplantation impact liver cancer survival in Asians? (website)
- Early events of in vitro KSHV infection (website)
- Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells (website)
- Effect of high fat diet on pancreatic cancer in IKKa deficient mice (website)
- Effectiveness of minocycline for reducing symptoms in pancreatic cancer patients (website)
- Effects of short-chain fatty acids on Epstein-Barr virus in B cell lymphoma (website)
- Elucidate and Modulate TGF-b Signaling in NK Cells for Glioma Treatment (website)
- Elucidating the in vivo Role of the p53 Apoptosis-Specific Target Gene Siva (website)
- Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma Cells (website)
- Enhancing radiation and cisplatin HNSCC cell killing by inhibiting mitochondrial (website)
- Epigenetic and clinical impact of SMARCB1 loss in cancer (website)
- Evaluating the impact of KRas codon bias on pancreatic cancer (website)
- Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St (website)
- Evaluation of Treatment Underreporting Using SEER-Medicare Data (website)
- Examining role of splicing factor mutations in myelodysplastic syndrome (PQ11) (website)
- Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom (website)
- Exploring the relationship of Vitamin D and childhood brain tumors (website)
- Fanconi anemia pathway in DNA damage repair (website)
- FISH assay identifying oral cancer patients at low risk of lymph node metastasis (website)
- Four-Dimensional Mri For Image-Guided Radiation Therapy For Pancreatic Cancer (website)
- Function of ADAR1 in Hematopoietic and Leukemia Stem Cells (website)
- Functional analysis of leukemic CREBBP mutations (website)
- Gadd45 stress sensors in leukemia (website)
- Genetic Risk Factors for Ewing’s Sarcoma (website)
- Genome-wide Identification of DNA Methylation Biomarkers in AML (website)
- Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors (website)
- Genomics of AML: Contribution of Cytokine Signaling Pathways to Leukemogenesis (website)
- Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk (website)
- Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer (website)
- G-quadruplex in Translational Regulation and Cancer Therapy (website)
- GUCY2C targeted adoptive T cell therapy to treat metastatic colorectal cancer (website)
- Hdac3 as a therapeutic target in BCL6-dependent lymphoma (website)
- Head and Neck squamous cell carcinoma radiation response modulation by HPV (website)
- Hepatocyte Nox proteins in the pathogenesis of hepatocellular carcinoma (website)
- Humanized Anti-Trop2-SN-38 Conjugate For Advanced Pancreatic Cancer (website)
- Hypoxia Image-Guided Radiation Therapy (website)
- Identification of regulatory cancer risk SNPs for chemoprevention discovery (website)
- Identifying Cancer Health Communication Channels for Hispanic Audiences (website)
- Identifying rare haplotype-environment interactions using Logistic Bayesian Lasso (website)
- IGF1R: A candidate oncogene in pediatric high grade gliomas (website)
- IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma (website)
- Image-guided thermo-chemoembolization for treatment of liver cancer (website)
- Immune Evasion by Multiple Myeloma: Role of the Rho Kinase Signaling Pathway (website)
- Immunobiology and immunotherapy of pancreatic cancer (website)
- Impact of chlorhexidine bathing on reducing infections in children with cancer
- Impact of genetic variation on response to GO therapy in COG-AML clinical trials (website)
- Improved therapeutic approaches for hematological disorder treated with tyrosine (website)
- Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive (website)
- In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22) (website)
- Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis (website)
- Inhibition of Autophagy Enhances Anti-Angiogenic Efficacy in Intracranial Glioma (website)
- In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma (website)
- Integrative Cancer Genomics: Drivers, Pathways and Drugs (website)
- Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis (website)
- Interplay of Tumor Microenvironment and MUC4 in Pancreatic Cancer (website)
- KillerRed Assisted Mutagenesis to discover cancer drug resistance genes (website)
- Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans (website)
- Linking tumor chemoresistance to TLR variants that mediate damage chain reaction (website)
- Live Cell Interferometry for Quantifying Mass Transport in Cancer (website)
- Magnetic-vortex microdiscs for glioma therapy (website)
- Massively Parallel Sequencing for Familial Colon Cancer Genes (website)
- Measles Virotherapy for Multiple Myeloma (website)
- Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death (website)
- Mechanisms of Metabolic Gene Mutations in Cancer (website)
- Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML (website)
- Mechanistic Studies of MUC4 and NGAL in Pancreatic Adenocarcinoma (website)
- Metabolic contribution to cell viability and therapy resistance in the acute (website)
- Metabolic Reprogramming: Essential Role and Early Marker of MGUS Progression (website)
- miRNA Biomarkers for Hepatocellular Carcinoma Associated with Viral Hepatitis (website)
- Mitochondrial Homeostasis in Metabolically Distinct Subsets of B-Cell Lymphoma (website)
- Models for Consortium Level Analysis of GxE Interaction in Complex Disease (website)
- Modulation of Radiation-induced Brain Injury in the Nonhuman Primate (website)
- Molecular analysis of the function of BRCA1-TONSL complexes (website)
- Molecular Basis for Localization and Activation of Focal Adhesion Kinase (website)
- Molecular mechanisms of B cell malignant transformation (website)
- Molecular Programs for Stem Cells of Hematological Malignancies (website)
- MR Imaging of IDH Mutational Status in Brain Tumors (website)
- MUC1 Roles in ovarian cancer pathogenesis and immune therapy (website)
- Murine Model of HCV-Associated Human Liver Cancer (website)
- Myb, a key driver of pancreatic cancer progression and metastasis (website)
- MYCN-induced calcium and magnesium signaling regulates Neuroblastoma progression (website)
- Nanoscale proteomic profiles of hypoxia pathways to develop biomarkers of renal c (website)
- Neurocognitive and Family Functioning at End of Therapy in Pediatric Brain Tumor (website)
- Non-invasive sampling of DNA markers for pancreatic cancer screening (website)
- Novel anti-ganglioside therapy (website)
- Novel Hedgehog Receptors as Therapeutic Targets In Pancreatic Cancer (website)
- Novel L-threo-sphinganines for ceramides-based cancer therapy (website)
- Novel Pathogen Associated Cancers (PQ12) (website)
- Nuclear receptor LRH-1 in pancreatic cancer (website)
- Omega-3 Fatty Acid Effects on Pancreatitis and Adenocarcinoma Development (website)
- Online Problem-Solving Skills Training for Mothers of Childhood Cancer Patients (website)
- OPPC targeting to improve pancreatic cancer treatment (website)
- Osteosarcoma Translational Research (website)
- Other functions r&d- biomedical (basic research) (website)
- Other functions scalable automated brain tumor segmentation (website)
- Other functions topic 277, developing bh3 profiling as a companion diagnostic fo (website)
- Ovarian Cancer: Prevention of the Disease and Its Recurrence (website)
- Parental age at birth and risk of adult-onset cancer in female offspring (website)
- Patterns of Care (POC) Quality of Care Dx Yr 2011 (website)
- Peptide-targeted alpha-particle emitting phage for ovarian cancer therapy (website)
- PET Enabled Microspheres for Radioembolization of Liver Tumors (website)
- Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment (website)
- PKCz;a novel therapeutic target for pancreatic cancer ‘stem cells’ (website)
- Post GWA Studies in Testicular Germ Cell Tumors (website)
- Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma (website)
- Prime/Boost Vaccine to Prevent Hepatocellular Carcinoma (website)
- Prospective Study of Serum MIS and Gynecologic Cancer Risk (website)
- Protein Biomarkers in Childhood Acute Myeloid Leukemia (website)
- Quantitative and Spatial Optimization for Designing Cancer Therapeutics (website)
- Rapid Testing of Drug-Resistant BCR-ABL(+)Leukemia Cells (website)
- Real-time prediction of thermal ablation-induced cell death by echo decorrelation (website)
- Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma (website)
- Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia (website)
- Response To Therapy For Patients With Glioma Using Hyperpolarized C-13 Pyruvate (website)
- Reverse ChIP: Sequence-specific extraction of DNA-bound histones for analysis of (website)
- RF-SRC: A Unified Data Tool (website)
- RNA from Brush Cytology to Identify Aggressive Squamous Cell Carcinoma (website)
- Robust rank-based methods and detection of GXE in cancer etiology and survival (website)
- Role of Ascl1 in glioma (website)
- Role of Collaborator Proteins in Hoxa9-Mediated Leukemogenesis (website)
- Role of HSF1 in B cell activation and lymphoma (website)
- Role of liver fluke granulin in cholangiocarcinogenesis (website)
- Role of miRNA-375 in Invasive Phenotype of Head and Neck Squamous Cell Carcinoma (website)
- Role of PGDH in leukemia pathogenesis (website)
- Role of Reishi on cell surface proteins and signaling modulation in IBC (website)
- Role of TTK/Mps-1 upregulation by Ral GTPase activation in pancreatic oncogenesis (website)
- ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia (website)
- Selective Differentiation of Glioblastoma Stem Cells (website)
- Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach (website)
- Signal processing for accurate detection of copy number variants in cancer (website)
- Simultaneous attack of epithelial and stromal compartments in pancreatic cancer (website)
- Southern Oncology Network on Adverse Reactions (SONAR) – Focus on Tyrosine Kinase (website)
- Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma (website)
- Staging of upper tract urothelial cancer with optical coherence tomography (website)
- Statistical Strategies for Establishing Etiologic Heterogeneity of Tumors (website)
- Strategies to Improve Kaposi’s Sarcoma Outcomes in Zimbabwe (website)
- Studies of Lymphoma Suppression and DNA Repair (website)
- Super-infection and virus spread during chronic hepadnaviral infection (website)
- Suv39H Targeted Therapy for Treatment of Childhood Rhabdomyosarcoma (website)
- Systematic Development of Novel, Druggable Cancer Targets (website)
- Targeted Glycomics and Affinity Reagents for Cancer Biomarker Development (website)
- Targeting a non-canonical RAS-driven pathway in pancreatic cancer (website)
- Targeting an ATM-dependent metabolic pathway and FLT3 for AML therapy (website)
- Targeting c-MYC Overcomes Temsirolimus and Cisplatin Resistance of Ovarian Cancer (website)
- Targeting HMGB1-mediated Autophagy in Cancer Therapy (website)
- Targeting Leukemia Stem Cells with Dietary Selenium (website)
- Targeting MUC4 for chemosensitization of pancreatic cancer (website)
- Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics (website)
- Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma (website)
- Targeting the aberrant kinome-epigenome in AML (website)
- Targeting the ERCC1/XPF nuclease for cancer therapy (website)
- Targeting the let-7-HMGA2 Network in Metastatic Progression in Pancreatic Cancer (website)
- Targeting Tumorigenic Pathways in Glioblastoma with Oncolytic HSV (website)
- Testing of novel anti-cancer compounds Curaxins against pancreatic cancer (website)
- The anti-senescence activity of trefoil factor 1 (website)
- The effects of dexamethasone on tumor and microglial cells in glioma (website)
- The Functional Analysis of Ovarian Cancer Susceptibility Locus 9p22.2 (website)
- The interaction of Burkitt’s lymphoma cofactors EBV and Plasmodium (website)
- The role of a histone H4 phosphorylation in drug resistance (website)
- The Role of Eya3 as a downstream target of EWS Fli1 in Ewings Sarcoma (website)
- The role of gremlin in regulating the differentiation of glioma stem cells (website)
- The role of HO-1 in Flt3-ITD positive AML proliferation and drug resistance
- The Role of IKK and NF-kappaB in Controlling mTOR Signaling and TSC Progression (website)
- The role of mitogen-activated protein kinase phosphatase-1 in tumor progression (website)
- The Role of NPM-ALK Signaling in Tumor Cell Metabolism (website)
- The Role of Stroma-derived Soluble TbetaRIII in Neuroblastoma (website)
- The Roles of Microglia and Macrophage Populations in the Glioma Microenvironment (website)
- The Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics (website)
- Tissue Factor splicing and pancreatic tumor progression: pilot studies (website)
- TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance (website)
- Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer (website)
- Tumor-targeted anti-CK2 RNAi for treatment of HCC (website)
- Understanding Mechanisms of Resistance to Anti-angiogenic Treatments (website)
- Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer (website)
- Utilizing proteoglycan biology to develop a novel treatment for brain cancers (website)
- Validation of a risk model for stage I lung adenocarcinoma (website)
- Vascular mechanisms regulating breast cancer brain metastasis (website)
- Whole Genome Sequencing to Discover Familial Myeloma Risk Genes (website)
- Xenograft Model to Study Impact of CRLF2-Ligand in Hispanic Childhood B-ALL
- ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor (website)
2011
- 124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer (website)
- A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors (website)
- A genome-wide methylation study of epigenetic contributions to multiple myeloma (website)
- A new small molecule targeting agent and therapeutic for non-Hodgkins lymphoma
- A novel approach to target Rb mutant cancers (website)
- A Novel Modulator of Notch in Acute Lymphoblastic Leukemia (website)
- A Phase II proof-of-concept trial to study kinase inhibition in relapsed/refracto (website)
- A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma (website)
- Aberrant activation of HGF/MET signaling as a therapeutic target in AML (website)
- Aberrant Glycosylation Signature in Pancreatic Cancer (website)
- Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers (website)
- Allogeneic B Cell Responses (website)
- Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations (website)
- Allografting for Lukemia (website)
- Altered Glycolytic Pathway in in vitro Models of leukemia developed in hypoxia (website)
- Anti-beta2 microglobulin as a novel therapeutic agent in multiple myeloma (website)
- Antibody-interferon fusion proteins for treatment of B-cell malignancies (website)
- Apparatus and Method for Convection Enhanced Therapeutic Delivery (website)
- Approaches to discover and quantify apoptotic biomarkers for cancer treatment (website)
- Assisted Reproductive Technology & Risk of Childhood Cancer (website)
- ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
- Atm, Reactive Oxygen, And Cellular Responses To Hypoxia (website)
- Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy (website)
- Barrett’s Esophagus Translational Research Network Coordinating Center (website)
- Bilateral oophorectomy and cancer risk and mortality in African American women (website)
- Biobehavioral Mechanisms Facilitating Recovery From Stem Cell Transplantation (website)
- Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma (website)
- Biophysical and molecular dialogue of glioma cells and the brain microenvironment (website)
- Blood Cell-Spheres: Growth, Description, and Potential (website)
- BRIT1, a novel hepatocellular carcinoma tumor suppressor (website)
- Cancer Stem Cell Niche in Brain Tumors (website)
- Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma (website)
- Case GI SPORE (website)
- CD38 Pretargeted Radioimmunotherapy for Myeloma (website)
- CD40 Pathway in Pancreatic Adenocarcinoma (website)
- Cell Processing and Sample Distribution (website)
- Cellular diversity and clinical relevance of stem cells in pancreatic cancer (website)
- Cellular Predisposition to Retinoblastoma Tumorigenesis (website)
- Center for Environment-Mediated Drug Resistance in Pediatric Cancer (website)
- Characterization of Myeloid Tumor Suppressor Genes on Chromosome 5 (website)
- Characterizing a New Human Dendritic Cell Lineage and Its Role in LCH (website)
- Chemical Inhibitors of Rhabdomyosarcoma Self-Renawal (website)
- Chemoprevention of Peutz-Jeghers Polyposis in a Mouse Model by Niclosamide (website)
- Clinical Production and IND enabling Studies for PSCA Minibody Imaging in Pancrea (website)
- Clinical Translation of Deformation Compensation for Image-Guided Liver Surgery (website)
- Communication Skills Intervention to Promote Transition into Survivorship (website)
- Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies (website)
- Conducting Research in Pediatric Hematology/Oncology
- Conformal Total Body and Marrow Irradiation for Leukemia (website)
- Control of GVHD with Retained GVT (website)
- CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res (website)
- CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation (website)
- Determinants of late cardiovascular morbidity among survivors of hematopoietic ce (website)
- Develop and Characterize a Novel Animal Model of Pancreatic Cancer (website)
- Developing a plectin-1 targeted imaging agent for the detection of pancreatic can (website)
- Development Of A Rapid In Vitro Screening Assay For Detection Of Cancer Biomarke (website)
- Development of aptamer-based detection and therapy strategies for ovarian cancer (website)
- Development of dihydroartemisinin as a novel preventive agent for prostate cancer (website)
- Dietary Prevention of Obesity-Enhanced Liver Cancer (website)
- Discovery and Validation of Tumor Immunoevasion Mechanisms (website)
- Dissecting the Role of Src Family Kinases in Breast Cancer Brain Metastasis (website)
- DNMT3A mutations in acute myeloid leukemia (website)
- Dual Targeting of MEK and EGFR Signaling Pathways in Advanced Pancreatic Cancer (website)
- Elucidating the function of the widely inactivated phosphatase PTPRD in the molec
- Elucidating the function of the widely inactivated phosphatase PTPRD in the molec (website)
- Elucidating the Role of STAT3-Dependent Autophagy in Hepatocellular Carcinoma (website)
- Endocrine Targets for Prevention of Lung Cancer (website)
- Enhancing Treg Immune Reconstitution After Stem Cell Transplant (website)
- Enzyme-delivery scaffold technology for targeted cancer killing (website)
- Epigenetic alterations underlying tumorigenic potential of Glioblastoma Cells (website)
- Epigenetic therapy with 3-deazaneplanocin A and gemcitabine for pancreatic cancer (website)
- Escape from gammaherpesvirus-induced mRNA destruction (website)
- Exome-wide screening for common mutations in lymphoma (website)
- Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy (website)
- Ezh2 in MLL-AF9 mediated acute myeloid leukemia (website)
- FitFab 4 Survivors (website)
- FLT-PET/CT for Therapy Monitoring of DLBCL (website)
- Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma (website)
- Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma (website)
- Genetic dissection and inhibitor targeting of Rac signaling in pancreatic cancer (website)
- Genetic Therapy for Fanconi Anemia (website)
- Genome-Wide Association Study of Childhood Leukemia by Hispanic Status (website)
- HCV Strain Variation and HCC (website)
- Hedgehog Palmitoylation as a Novel Target for Inhibiting Pancreatic Cancer (website)
- Heparanase regulation of osteolysis in multiple myeloma (website)
- Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations (website)
- High Resolution Microendoscopy for the Detection of Esophageal Neoplasia (website)
- Histone methyltransferase EZH2 in liver pathophysiology and carcinogenesis (website)
- Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation (website)
- HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion (website)
- Humoral and cellular immunity in polyomavirus-linked Merkel cell carcinoma (website)
- Identification and Characterization of Gene Fusions in Lung Adenocarcinoma (website)
- IEX-1 as a potential biomarker for early detection of myelodysplastic syndromes (website)
- Ikaros-based epigenetic regulation of T cell leukemogenesis (website)
- Imaging for Y90 Microscphere SIRT Planning (website)
- Improving Cord Blood Transplantation (website)
- Improving Immune Reconstitution via Cytokine-Mediated Expansion of Transplanted (website)
- In vivo functional characterization of Myelodysplasia/Myeloid Leukemia Factor (website)
- Incorporation of Genomic Sequencing into Pediatric Cancer Care (website)
- Infectious origins of childhood leukemia (website)
- Inhibiting the Survival And Proliferation Of EBV-Associated Tumor Cells (website)
- Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma
- Initiation and evolution of the ovarian cancer microenvironment (website)
- Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer (website)
- Integrative Oncogenomics of Multiple Myeloma (website)
- Interplay between Intrinsic and extrinsic force and glioma pathogenesis (website)
- Invadopodia assembly in pancreatic tumor-associated fibroblasts (website)
- Investigation Of The Roles Of Nuclear Receptor Fxr In Hepatocellular (website)
- Long-Term Follow-up Core
- Mammographic Breast Density and Ovarian Cancer (website)
- Markers and therapeutic strategies for overcoming chemoradiotherapy resistance (website)
- Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas (website)
- Mechanism of Radiation Mediated Clearance of HPV Positive Head and Neck Cancer (website) 2013
- Mechanisms of Hedgehog Target Gene Selection in Development and Cancer (website)
- Mechanisms of subtelomere recombination in telomerase deficient tumors (website)
- Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin (website)
- Memory T Cells in the Tumor Microenvironment
- Mentored Quantitative Research Career Development Award
- Metabolic Regulators of Tumor Cell Growth (website) 2012
- Metabonomics Studies of Human Diseases (website)
- micro RNA TARGETING of normal & leukemia stem- progenitor cells (website)
- Microenvironmental regulation of the cancer stem cell phenotype by integrin a6 (website)
- Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells (website)
- Mnk Pathways and IFN-responses in Malignant Cells (website)
- Models to predict prognosis and benefit from adjuvant therapy in renal cell carci (website)
- Modulation of miR-31 by dietary zinc deficiency in rat esophageal carcinogenesis (website)
- Molecular determinants of breast cancer malignancy (website)
- Molecular Epidemiology of Pediatric Germ Cell Tumors (website)
- Molecular Evolution of Multifunctional DNA Nanoparticles (website)
- Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis (website)
- Molecular Pathology of t-AML (website)
- Molecular Targets in T Lineage Leukemia (website)
- MR-Guided Precision Tliermal Tfierapy of Retroperitoneal Tumors (website)
- MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer (website)
- mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity (website)
- Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy (website)
- Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett’s Esopha (website)
- Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22
- Myeloma stem cell targeting by liver x receptors (website)
- Nanocaged Metal Tags in Massively Multiplexed Leukemia Bioassay and Beyond (website)
- NcoA5, a unique nuclear receptor coactivator in hepatocarcinogenesis (website)
- New Therapeutic Targets in AML (website)
- Non-Cell Autonomous Functions of N-cadherin in KRas-driven Preneoplastic Lesions (website)
- Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma (website)
- Novel Combination Therapy Against Pancreatic Cancer (website)
- Novel Mcl-1 inhibitors for Pancreatic Cancer Therapy (website)
- Novel MRI Vascular Biomarkers for the Detection of Tumor Invasion (website)
- Novel Single Domain Antibodies with Multivalency and Multispecificity (website)
- Novel targeted therapeutics for multiple myeloma (website)
- Oncogenesis and myeloid transcription factors in AML (website)
- Optical Imaging of Chemotherapy for Brain Tumors (website)
- Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry (website)
- Oxygen as a master immunologic switch (website)
- Pancreatic Juice Biomarker for Pancreatic Cancer (website)
- Parental Occupational Pesticide Exposure Assessment and Childhood Leukemia Risk (website)
- Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma (website)
- Pathway Specific Imaging in VHL Deficient Renal Cancer (website)
- Patient sample repository and specialized flow cytometry (website)
- PDE4B and pharmacoethnicity of childhood leukemia (website)
- Personalizing Nanoparticle Therapy
- PET Enabled Microspheres for Radioembolization of Liver Tumors
- PET tumor and proliferation imaging via cationic amino acid transport (website)
- Pharmacogenetics of Cyclophosphamide ADRs in (website)
- Phase 1 of AR-42 in relapsed CLL, lymphoma, myeloma (website)
- Photoacoustic Microscopy Of Neovascularization In Renal Cancer Growth And Therapy (website)
- PMLRARalpha and PML directly regulate Fas-mediated apoptosis in vivo (website)
- Post-translational regulation of MLL in leukemogenesis (website)
- Preclinical Development of iRGD for Pancreatic Cancer (website)
- Predictive biomarker development in lung cancer: ROS1 chromosomal rearrangements (website)
- Preliminary Evaluation of FDG-PET with anti-IGF-1R Targeted Therapy in GISTs (website)
- Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy (website)
- Prognostic Genetic Biomarkers for Secondary Leukemia (website)
- Prospective Oral HPV and Risk of Head and Neck Cancers (website)
- Protective Immunity Against Herpesvirus Infections (website)
- Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers (website)
- PTPMT1 Regulates Cancer Cell Bioenergetics by Suppressing Oxidative Metabolism (website)
- Quantitative MRI-Guided Nanoembolization for Liver Cancer (website)
- Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease (website)
- Rapid Analysis of Intraoperatively Acquired DTI for Identification of Key White M (website)
- Rational combination of EGFR and Hedgehog inhibitors in head and neck cancer (website)
- Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B (website)
- Reducing Complement Inhibition to Treat Leukemia and Lymphoma (website)
- Regulation of caspase 9 RNA splicing in NSCLC cancer (website)
- Regulation of Extracellular Matrix 1(ECM1) and its role in thyroid carcinogenesis (website)
- Regulation of lipogenesis by lysophosphatidic acid in ovarian cancer (website)
- Regulation of Myc-Mediated Tumorigenesis (website)
- Regulation of p120-catenin tumor supressor activities (website)
- Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma (website)
- Retrotransposon instability in glioblastoma multiforme (website)
- Risk of Non-Hodgkin’s Lymphoma in Relation to Tricyclic Antidepressant Use (website)
- Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells (website)
- Role of ASXL1 mutations in myeloid malignancies (website)
- Role of GSK-3 isoforms in Pancreatic Cancer (website)
- Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma (website)
- Role of p190RhoGEF (Rgnef) in cell motility and tumor progression (website)
- Role of PKC iota in metaplasia and initiation of pancreatic cancer (website)
- Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor (website)
- Role of the Fractalkine Signaling in EOC (website)
- Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors (website)
- RON Receptor in Pancreatic Cancer Biology and Therapy (website)
- RRSS Improving SES Data: Linkage w State Vital Records, Birth Certificate Data (website)
- See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery (website)
- Serum glycoprotein markers of cancer using an ion mobility/mass spec approach (website)
- Serum microRNA signature as prospective HCC biomarker in HBV patients (website)
- Small molecular weight eNOS inhibitors for the treatment of pancreatic cancer (website)
- Stem Cells And The Origins of Barrett’s Esophagus (website)
- Stopping the Start: Understanding PanIN Initiation and Progression (website)
- Survivorship: Mentoring and Bridging Primary Care and Oncology (website)
- Targeted Delivery of a Novel Synthetic Curcumin Analog, EF24 to Glioblastoma and (website)
- Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy (website)
- Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow (website)
- Targeted therapy of pancreatic cancer with in vivo radionuclide generator (website)
- Targeting Akt Activation in CLL (website)
- Targeting Alloreactivity for Leukemia Eradication (website)
- Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia (website)
- Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma Progression (website)
- Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL (website)
- Targeting vFLIP for the treatment of KSHV-associated malignancies (website)
- Tas::75 0849::tas sbir topic 292 phase i development of molecular pharmacodynami (website)
- Tas::75 0849::tas topic 255 development of a targeted therapy for acute myeloid (website)
- Tas::75 0849::tas topic 255 selective and potent inhibitors of tumor specific gl (website)
- The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma (website)
- The glucocorticoid receptor as signal integrator: studying ALL drug resistance (website)
- The role of a novel BRCA1 associated complex in DNA damage response and tumor sup (website)
- The Role of ATM in Suppression of Lymphomas (website)
- The role of c-Maf in Stem cells in Leukemia (website)
- The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene (website)
- The role of microRNAs in leukemic initiation and maintenance (website)
- The role of Nkx2-1 in lung adenocarcinoma (website)
- The Role of the PI3K-AKT Pathway in Melanoma Brain Metastasis (website)
- The vascular niche in glioma propagation and resistance to therapy
- Therapeutic delivery of anti-miR oligos to hepatocellular cancer (website)
- TOR signaling and autophagy in obesity-promoted liver tumorigenesis (website)
- Training Program in Pediatric Cancer Epidemiology and Control (website)
- Transglutaminase Modulated Tumor-Stroma Interaction in Pancreatic Cancer (website)
- Translational Regulation of the Inflammatory Breast Cancer Stem Cell (website)
- Transponson-based screens for genes involved in acute lymphoblastic Leukemia (website)
- Trisomy 8 in hematopoiesis and myeloid leukemia (website)
- Tumor microenvironments determing migration, dissemination and dormancy (website)
- Tumorigenic Role of the CUL4A Ubiquitin Ligase (website)
- Tyrosine kinase oncogenes in acute myeloid leukemias (website)
- Understanding the origin and pathogenesis of epithelial ovarian cancer (website)
- Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc (website)
- Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial (website)
- Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer (website)
- Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (website)
- Validation of copy number changes by MLPA as predictors of relapse in Wilms tumor (website)
- Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses (website)
- Virus-Targeted Therapy for Malignancies (website)
2010
- A bifunctional nanomedicine for both specific imaging and targeting therapy of an (website)
- A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma (website)
- A New Method for Improved Targeting in Image-guided Abdominal Interventions (website)
- A Novel ROS Controlling Kinase (website)
- A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients (website)
- A20 Promotes Glioma Stem Cell Mediated Tumorigenesis (website)
- Academic-Industrial Partnership to Develop & Test Esophageal Cancer Imaging Tools (website)
- Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas (website)
- An integrated systems biology approach for ovarian cancer biomarker discovery (website)
- Analysis of a novel regulator of hepatocellular carcinoma (website)
- Analysis of the leukemic stem cell niche in chronic myeloid leukemia (website)
- Apical-basal polarity signaling in glioblastoma (website)
- Assessing pancreatic cancer susceptibility to ceramide-mediated cell death (website)
- Autoregressive Joinpoint Analysis of Cancer Trend Data (website)
- Bayesian Risk Modeling of Racial-spatial Interactions Among Childhood Cancer Hist
- BCR/ABL-PI-3k-ROS pathway induce genomic instability …. (website)
- BETR Therapy for Herpesvirus-Associated Tumors (website)
- Biosensor design for detection and analysis of complex signal patterns in cancer (website)
- Brain Endothelial TNF-R1 Can Function to Inhibit Angiogenesis (website)
- CD147 as a Novel Target in Head and Neck Cancer (website)
- Cell Cycle Regulation and Adult T Cell Leukemia (website)
- Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa (website)
- CITP-Based Selective Tissue Proteome Enrichment (website)
- Columbia-South Africa Training Program for Research on HIV-associated Malignanci (website)
- Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia (website)
- Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project (website)
- Copy number variations (CNVs) in neuroblastoma (website)
- CRLF2 signaling in B-cell acute lymphoblastic leukemia (website)
- Decoding the MST1 and MST2 kinases in cellular physiology and tumor suppression (website)
- Defining lineage-specific determinants of K-Ras « addiction » in human cancers (website)
- Detection of Pre-Invasive Pancreatic Cysts Using Protein and Glycan Biomarkers (website)
- Developing Research Capacity for AIDS Malignancy in Kenya (website)
- Development and validation of an imaging-based biomarker of therapeutic efficacy (website)
- Development of a multimarker urine-based test for early diagnosis and screening o (website)
- Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy (website)
- Development of Microscopic Spectral Markers for Diagnosis of Pancreatic Lesions (website)
- DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome (website)
- Diffuse Optical Monitoring of Head and Neck Tumor Therapy (website)
- Discovering chemical tools for acute myelogenous leukemia (website)
- Dissecting sarcoma complexity via innovative microRNA and informatics approaches (website)
- Dissecting the roles of stellate cells in pancreas cancer progression (website)
- Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia (ALL) (website)
- Dynamic multimodal imaging of tumor hypoxia and vascular profiles in glioblastoma (website)
- EBNA1 Functions Required in Burkitt’s Lymphomas and Other Immortalized B-Cells (website)
- EKLF (KLF1): A Potential Tumor Suppressor? (website)
- Engineered lymphocytes for the treatment of hepatocellular carcinoma (website)
- Engineering tyrosine kinase-activated caspases for selective cancer cell killing (website)
- Enhancing the Biomedical Computing Platform for Pancreatic Cancer Research (website)
- Enzyme-instructed self-assembly for anticancer nanomedicine (website)
- Epidemiology of Ovarian Cancer in African-American Women (website)
- ErbB Receptor Signaling in DEN-induced Murine Hepatocarcinogenesis (website)
- Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients (website)
- Exercise-mediated protection against brain metastases (website)
- Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer (website)
- Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors (website)
- Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer (website)
- Functional Validation of Pancreatic Cancer Progression Biomarker (website)
- Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology (website)
- Generation and utility of NADPH oxidase inhibitors (website)
- Genetic Approaches to Pancreatic Cancer Progression (website)
- Genetic Predictors of AML Treatment Response (website)
- Genomic Approaches to Defining Inherited Basis of Childhood Cancer (website)
- GLI1 and Cancer Stem Cells in Ewing Sarcoma (website)
- Hedgehog signaling in head and neck cancer stem cells, and its role in resistance (website)
- High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples (website)
- HTLV I Tax1 protein chemosensitization of p53 mutant tumors (website)
- Identifying a Hypoxia Inducible Factor target profile in Renal Cell Carcinoma tum (website)
- Identifying Malignant Cell Signaling from Protein Interactions an Polyomic Data (website)
- IHC Test for BRCA1 Hereditary Ovarian Cancer (website)
- Immunologic targets in Myeloid Leukemia (website)
- Impact of Vaccination against GM2, GD2 and GD3 on Disease Free Survival in Resect (website)
- Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment
- Improving T-cell therapies for neuroblastoma (website)
- Inactivation of Hdac3 in the cause, prevention, and treatment of HCC (website)
- Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma (website)
- Inhibitor of Adrenal Steroid Synthesis for Cancer Treatment (website)
- Innovative Delivery Strategy for CaSm Gene Therapy in Pancreatic Cancer (website)
- Integrated Imaging and Photothermal Ablation of Pancreatic Cancer Resection Margi (website)
- Interferon Responses in Myeloid Leukemia (website)
- International Case Control Study of Malignant Glioma (website)
- Investigations on the role of the CDK8 oncogene in colon cancer (website)
- K-Rta as a Novel SUMO and Epigenetic Regulator (website)
- Lentiviral-MGMT gene transfer into hematopoietic stem cells (website)
- Long-term Treatment Related CNS Injury in Survivors of Childhood Cancer (website)
- Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas (website)
- Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection (website)
- Mechanism of BCL6-dependent stem cell maintenance in B cell lineage leukemia (website)
- Mechanism of Merlin-mediated contact inhibition and tumor suppression (website)
- Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis (website)
- Mechanisms regulating epithelial mesenchymal transition in development and glioma (website)
- Metabolomic and Integromic Approaches to Identify Fingerprints for Early Detectio (website)
- microRNA-155 and Lymphoma (website)
- Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics (website)
- Mitochondrial Dysfunction and Chemoresistance in Malignant Gliomas (website)
- MLL in Hematopoiesis and Leukemia in the Zebrafish Model (website)
- Modulation of liver cancer by PPARbeta/delta (website)
- Modulation of RGS proteins and Ovarian Cancer Chemoresistance (website)
- Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma (website)
- Molecular interactions and restoration strategies of PTEN and p53 in gliomas (website)
- Molecular Pathogenesis and Therapy of ET and PMF (website)
- Molecular Risk Assessment in Hereditary Melanoma (website)
- Molecular Targeting Strategies in HNSCC (website)
- MRI for In Vivo Quantification of Yttrium-90 Microsphere Biodistribution (website)
- mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia (website)
- Multifunctional roles of homeobox gene DLX4 in ovarian cancer (website)
- Multiple Myeloma and Cancer Therapies via Largazole Analogs (website)
- Multipotent mesenchymal stem cell-like cells in pancreatic tumorigenesis (website)
- Myxoma Virus (MV) Oncolysis for treating human cancer (website)
- Nanoparticle-Directed Photothermal Ablation of Primary Brain Tumors guided by Mag (website)
- Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer (website)
- NK cell-myeloid cell crosstalk in patients with cancer (website)
- Non-Hodgkin lymphoma in women: reproductive, hormonal and genetic factors (website)
- Novel Approaches for Structural Determination of Cancer Stem Cell Glycans (website)
- Novel Biologically Targeted Therapy Against the Mer and Axl Receptor Tyrosine Kin (website)
- Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy (website)
- Novel Molecular Mechanism of Glioma Pathogenesis (website)
- Novel targeted therapies for BRCA-associated cancer (website)
- Obesity in ovarian cancer prognosis (website)
- Oncogene cooperation in glioma genesis (website)
- Optimizing Induction Conditions for Immunotherapeutic CTL (website)
- OSU-03012 therapy for glioblastoma (website)
- p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1 (website)
- P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance (website)
- PAARK4Kids-Pharmacogenomics of Anticancer Agents Research in Children (website)
- Papillary thyroid cancer and tumor-associated macrophages (website)
- Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer (website)
- Peptide-Based Vaccine Therapy for Childhood Malignant Gliomas (website)
- Phospho-valproic acid for pancreatic cancer prevention (website)
- Polyomavirus-Associated Human Cancers (website)
- Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer (website)
- Preclinical platform for theranostic nanoparticles in pancreatic cancer (website)
- Prediction Model: Breast Cancer in Women Irradiated for a Pediatric Malignancy (website)
- Predictors of myelodysplastic syndrome in Minnesota (website)
- Prognostic markers in metastatic melanoma (website)
- Protein Kinase D in oncogenic oxidative stress signaling (website)
- Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery (website)
- Quantitative glycoproteomics for pancreatic cancer studies (website)
- Radioimmunotherapy for Multiple Myeloma (website)
- Regulation of hepatic NKT cells by CDld+ liver cells (website)
- Regulation of microRNA-16 by benzyl isothiocyanate in pancreatic cancer (website)
- RhoB in cancer pathogenesis and as a target in combinatorial therapy (website)
- RNA from Brush Cytology to Detect Squamous Cell Carcinoma (website)
- Role of adhesin-receptor interaction in H. pylori-induced gastric carcinogenesis (website)
- Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer (website)
- Role of Fibroblasts, Myeloid Cells and Matrix in PDAC (website)
- Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies (website)
- Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis (website)
- Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
- Role of rac and reactive oxygen species in kaposi’s sarcoma viral oncogenesis (website)
- Role of Setbp1 in leukemic stem cell self-renewal (website)
- Role of the BMP SMADs in Oncogenesis (website)
- Role of Tumor Microenvironment in Ovarian Cancer Progression (website)
- Rpl22 as Biomarker of Prognosis and Therapeutic Response in T-ALL (website)
- Selective sensitization of pancreatic tumor cells to chemotherapy (website)
- Sex Chromosomes and Gender Disparity in HBV-Related Hepatocellular Carcinoma (website)
- Shared Genomic Segment Analysis for Localizing Multiple Myeloma Genes (website)
- Signal Transduction Pathways in CD30-positive Lymphomas (website)
- Simultaneous Tc-99m-MDP/I-123-MIBG Imaging of Neuroblastoma Using SPECT-CT (website)
- Smart Packaging: A Novel Technique for Localized Drug Delivery for Ovarian Cancer (website)
- Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers (website)
- Sunitinib Modulation of Cancer Immunotherapy (website)
- Targeting aberrant epigenetics by nanomedicine (website)
- Targeting ATDC with PARP inhibitors in pancreatic cancer (website)
- Targeting Cdc42 in leukemia stem cells (website)
- Targeting epigenomic signatures in non-hodgkin lymphoma for novel therapeutics (website)
- Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer (website)
- Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach. (website)
- Targeting myeloid-derived suppressor cells for gastric cancer prevention (website)
- Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside (website)
- Targeting PML for therapy in leukemia-initiating cells (website)
- Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment (website)
- Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles (website)
- Targeting the tumor matrix as anti-invasive and sensitizing strategy for glioma (website)
- T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia (website)
- The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma (website)
- The contribution of protein translation to tumorigenesis (website)
- The effect of p53 signaling on the metabolism and therapeutic response of glioma (website)
- The Meningioma Consortium: Genome-Wide Association Study (website)
- The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia (website)
- The Role of Cul4A in Genome Stability and Cancer Development (website)
- The role of DNA polymerase eta in DNA damage response and p53 activation (website)
- The Role of glypican-1 in Pancreatic Cancer Development and Progression (website)
- The role of microRNA, mir-30d, in the initiation and progression of cancer (website)
- The Role of MMSET in DNA damage response and Chemoradioresistance
- The role of MTG8 in genomic stability and colorectal cancer development (website)
- The role of PHF6 in T-cell acute lymphoblastic leukemia
- The Role of RECQL4 in Bone Development and Osteosarcoma (website)
- Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer (website)
- Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
- Thermally Targeted Cell Cycle Inhibitors for the Treatment of Pancreatic Cancer (website)
- Toxicity and Efficacy of Gold Nanoparticle Photothermal Therapy in Cancer (website)
- Translation of smart contrast agents for brain tumor characterization by MR (website)
- Trauma and Growth in Pediatric Cancer (website)
- Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer (website)
- Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival (website)
- Tyrosine Kinase Signaling in Cancer Cell Metabolism (website)
- Using mouse models to understand retinoblastoma initiation and progression (website)
- Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods (website)